

EH
case-control


dXA
FM
hz pna
molecular

Renal_ artery_ stenosis
exercise cardiovascular health
tertiary_ referral
devices heart_ failure

Liver disease
hospital_ mortalité
DESIGN
acute_de_ surgery heart
EC
breathing heart

DESIGN
heart_ failure Latin America

HF
mortalité



doctors


Heart
nordwest_ Unitedes
Nutrition heart_ failure
DESIGN
unilateral

heart_ failure
interventions

Heart

clin

trans


intermediate_frailty

CHF
dodson


air pollution heart_ failure
cardiovascular disease



hz MI
Heart_ failure
hemostasis
Remote_ischemic conditioning heart_ failure
Heart_ rate_variable cardiac
Heart_ failure uk

rates CHF

Sham-operated_ animals
policy



classified taxonomy

doxorubicin
cell Anand
hazards
complications
hf
blood_transfusions
Heart_ failure bisphosphonates
diuretic_utilisation heart_ failure
caspase heart_ failure
right_ heart_ failure pulmonary hypertension
benefits cardiovascular_system
HF
Internal_ reliability cronbach
hypertension




frailty heart_ failure
HR afterload_ burden

Hazard cox
RAS atherosclerosis
conditions
PSs
MicroRNAs heart_ failure disease
heart_ failure
Cardiology heart_ failure
heart_ failure ejection_fraction
implanted_ monitoring devices


Heart_ failure cognitive impairment mortality
LV fibrosis
Department_de_cardiology university_hospital
HFpEF
fréquence hf
autonomic_ balance
frailtyHF
hospital heart_ failure

inpatient medical conditions
Mitral_ stenosis heart_ failure
median_ followup
competitive
CO
heart_ failure
cognitive_fonctionnel
vasopressin congestive_ heart_ failure
cardiac_ transplantation
Jehovah_s Witness anemia
pde2HF


blacks

readmission
ET CHF
readmission

physician hospital
Median_ follow-up
Arrhythmia-related costs expenditures
Medication sst2
reliabilityHF
mortalité sts hm
réseau
propensity
mortalité random-effects
functional_capacité

surgical_ tactiques circulatory_ arrest
CHF
ejection_fraction sex bNP
Chronic_HF
etiology MR MS
hpEF
Cardiac_amyloidosis
Pigs antiarrhythmic medication
Robot-assisted training heart_ failure


biomarkers chronic_heart_ failure
Heart_ rate arterial_tension
therapy beta_blockade
hgb HRQol
cardiac inflammatory biomarkers
systolique_ dysfunction
ejection_fraction
hf cardiovascular_hospitalization
heart_ failure
US_ healthcare


trials
abnormal_ cardiac
drug Japan
avantages
risk
VO2max
ESRD
biomarkers
HRHF
mAIN_oUTCOME_measure tug
heart_ failure

quality_de_ life well-being
Heart ventricular ejection_fraction
VET aortic_tension
heart_ failureHF therapy
physician_continuité discharge
Heart_ failure public_ health
Trastuzumab cardiotoxicité breast cancer
Nights hospital coprimary_ outcome
Cardiac
albumin
Tolvaptan vasopressin receptor
moleculars heart_pathologie
Functional MS degenerative MR
Heart_ failureHF mortality
spironolactone heart_ failure
heart_ failure bisoprolol
cox hazards
stand-alone_Diagnos devicesHF
clinician expertiseHF

therapy
circulation

cPGs
MS surgery
pathophysiological

AHA ESC
gross_ income expenditure health
patients heart_ failure
lVAD implantation

dialysis implantation
cox proportional_ hazards
Seattle_ Heart_ Failure
heart_ failure


Coronary_angiography lesions
MS surgery echocardiography
Hemodynamic Fontan
off-pump sparing HeartMate
heart_ failure cox
Nordic_ walking heart_ failure
multiorgan_ failure sepsis
Pharmacological_ treatment acute_ heart_ failure
acute_ kidney injury
endothelial_fonctionnel dilatation
Psychometric_ testing Self-Care_de_ Heart_ Failure

new-onset AI surgical
grs CV
mortalité
deficits



nursing
race
QRs benefit
MS surgery
skeletal_ muscle_ abnormalités circulation
renin-angiotens-aldosterone heart_ failure
CHF unilateral renal DNx cardiac_ autonomic_ balance
acute_ heart_ failure
anaerobic heart_ failure
hz cardiac_ death
mAIN_oUTCOME readmissions
aac cardiac_ hypertrophy
postsystolique
Physician heart_ failure
medication resting_ hemodynamics
toxicity blood_tension
patient_ satisfaction
Mitral_regurgitationHF
hospital_ longitudinal
systolique_HF
Readmission hospital heart_ failure discharge
heart_ failure
progressive hypertension kidney_ failure
chronic_ kidney_ diseaseCKd
hz
ICU mortality
Nurses disease
ct dialysis-dependent
CHF
RM
économique savings coût
Western_ blot immunohistochemistry electron_microscopy
ischemic_ cardiomyopathy
idiopathic dilated_ cardiomyopathy
hz chromatin_ hyperacetylation
diastolique_ dysfunction peripheral_ artery_ disease
protein cardiac_sodium_ current heart_ failure
angiotensin receptor neprilysin_ inhibitor heart_ failure
hypertensive LV dysfunction MR MS
physicians hf
hypoalbuminemia heart_ failure
acute_ heart_ failure
benefits anemia heart_ disease

lVAD

management telehealth medicare
public reporting
Rhythm- and_ rate-control
sinus rhythm AF
filling_tensions
Myocardial_ infarction Wistar
cd hf
heart_ failure cardiac_ rehabilitation
ingenuity
Race spironolactone heart_ failure
proteinsTAC
MS mva
cRF
Mediterranean DASh food-frequency
social_support exercise
stay rehospitalization
odds ratios hospital_ clustering
hospitalisation heart_ failure
Nitroxyl hno heart_ failure
hf HFpEF
Heart_block pulmonary_ artery BiVP
Blacks VO2
Hospital_to-Home hospital_ readmission_reduction_ program congestive_ heart_ failure
Cardiac-resynchronization therapy heart_ failure
physician_continuité readmission_ after_discharge heart_ failure
recruitment compliance
diabetesEO-cFUs
health-related
af patients echocardiographic
MSHF surgical_ indication MS
Cardiac_fonctionnel pressure-volume conductance catheter
st2 benefit BB therapy
PVf recovery pp amplitude
congenital_ heart_ lesions
beta-blockers
cardiovascular events
surgical MS
diuretic_utilisationHF
CAD systolicHF
bioinformatic
change lVET
resistin inflammation metabolism heart
coronary_ disease heart_ failure
hypoalbuminemia lVAD
cardiac_ remodelling
Fat cachexia ventricle heart_ failure complicity
atrial_ fibrillationAF heart_ failure
deficit biological mortalité
résistances heart_ failure
avd VVD free_ wall
incidence ESRD
Exercise_intolerance chronic_ heart_ failure
subclinical_ atherosclerosis
remodelling hf haemodynamic neuronal_ stressors
ventricular_fonctionnel heart_ failure
heart_ transplantation left ventricular_assist_ device
eCGs electrocardiographers
heart_ rate

complications dialysis
ffffff body_ weight CC
fréquence hf
Cardiac_ cachexiacc changes
Southeastern_ Minnesota hf
multihospital heart_ failure
hff
proteome_de_ HDl particles shotgun
branch_block_électrique_ activation
heart_ transplant ECCT
Protective effects ed endothelial_fonctionnement
stroke heart_ failure
ECCT advanced_heart_ failure
hHF dp-4 inhibiteurs drugs
holosystolique_ murmur heart

heart_ failure
hf
pharmaceutically
hypotension
bt dt implantation
mortalité
Peak_vo2
ST2 plasma
discharge medication
lesions septal
extubated blood_ loss transfusion
mortalité iCD-HF
miRNAs cardiac_pathogenesis
biomarkersHF


FINDINGs
hospitals
trastuzumab-related CHF
transplants
Healthy
hospitals
économique
patient_ safety
Wilcoxon signed-rank
ventricular_assist device ventricular_support
psoriasis atherosclerosis cardiovascular events Rotterdam
Renal_ artery_ stenosisRAS peripheral_ arterial
Heart_ failure rheumatoid_ arthritis tNF
Coronary_ artery_ diseaseCAD systolique_ heart_ failureHF
mortalitéHF hospital_admissions transplant ventricular_assist device
validité
hospitals
heart_ failure ejection_fraction
renal_ denervation autonomic_ balance rabbits heart_ failure
regulatory_subunitRI hz
Nfat mir-25 transcription_ factor Hand2 heart_ failure
VEGF cardiac_fonctionnement remodeling
Myxomas right_ atrium pulmonary_ arterial
Right_ atrial_ myxoma pulmonary_ embolism right_ heart_ failure
Orthotopic_ heart_ transplantation oHT end-stage_heart_ failure
coronary_ heart_ disease stroke heart_ failure
β-blockerBB sST2
eplerenone
cPET rehabilitation CHF
ECCT cardiac_ transplantation
technique malfunctioning HeartMate lVADs
Heart_ failureHF cardiovascular
medications heart_ failure

quality_of_ life mlf
Patients heart_ failure medication
resistin decline ejection_fraction
Pediatric heart_ failureHF
readmissions heart_ failure
ischemic_inflammatory_ abdominals MT
caspase paced_Myocardium
aCR CMS
MedLineEMBAse cINAHL
renal_ dysfonction transplant morbidité
benefits anemia heart_ disease
Heart_ failure disease
hf saxagliptin sitagliptin
evidence-based_therapies fe
dysfonction pump_ failure driveline_ injury pump
hf
hospital_discharge
Renal DNx circulation_ plasma CHF-inv rabbits
hct germline_ DNA
lVAD implantation
derivation CAD


blood_ work medication
HDl-bound malondialdehyde HDl-induced EC
trastuzumab
NP ED

EH hpEF
ST2 ambulatory patients heart_ failure
hospital_discharge patients heart_ failure
echocardiograms remodeling
Titin hypophosphorylation myocardial
Cardiac Mammalian mena heart_ failure
apoptosis canine chronic_ heart_ failure tachycardia
benefitRAS- β-blocker_uptitration hpEF
coronary_ artery_ diseaseCAD
LV filling_tension hz
Gastrointestinal_ bleeding ventricular_assist devices cardiac_ nurse
lVAS bridge_ to_ transplantation therapy
heart_ failure
cPCs functional_capacité VO2
Cardiac_ hypertrophy energie_ metabolism
eAST rhythm_control_therapy cardiovascular complications AF
fréquence heart_ failure aging
Nicorandil doxorubicin
radiological signsHF
Heart heart_ failure arrhythmias
Framingham_ Heart_ Study hf
ED intubations congestive_ heart_ failure
diuretics congestive_ symptoms heart_ failureHF
aCP clinical_ practice guidelines
bottleneck stent chronic_ myocardial_ischemia heart_ failure pigs
mortalité iCD-HF
inpatient records hf
aRIC_HF
therapy cardiovascular
pneumonia conditions
therapy

paedic_ cardiac transplants
AF-free catheter ablation sinus rhythm
NOc admission discharge
implantation cRT
HRQoL hgb
degs osprey réseaus
iron
ED CHF
deficitSD
Medicare post-acute_care_transfer_policy
benefit QRs
clinical change
vegetables nuts grain mortality
benefit
validité
QT_ intervals SDQT
ventricular_contractile_ reserve pulmonary_ hypertension
Heart_ rate aortic_ blood_ flow doxorubicin
acute_ autonomic_ nervous_system_ modulation QTVHF
cardiovascular_ deathHF btes
cardiac_resynchronization_therapy dialysis-dependent heart_ failure
rvpo BiVP RS_synchrony CS
ventricular-arterial coupling SV
Myocardial pde expression hz
mapping myocardial_ fibrosis
BAT sympathetic_ outflow parasympathetic activity
resistin acute anthracycline-induced_ cardiotoxicity
skeletal_ muscle_ mass VO2
active
emergency_ cardiac_ catheterization extubated
atrial_ fibrillation pacemaker
pump_ exchanges pump thrombosis hemolysis
World_ Health_ Organization hz
myocardial_ tissue pka
body_ mass_ index cRF treadmill_ exercise
injections
diastolic_ failure cardiomyopathic
autonomic_ nervous_system_ activity QTV
psychosocial factors heart_ failureHF
hospitalisations readmissions mortalité
heart_ failure high-density_ lipoprotein
ed visits CHF intubation
Frailité elderly health

Medicare fee-for-service
physician_continuity conditions hospital_discharge
SDSD

bisoprolol mortality
PSs social_support btes
ethics_ Rounds
high-risk
cardiac_ stress β-AR


heart_ rate ivabradine ventricle heart_ failure
ecardiographic reverse_ remodeling cardiac_resynchronization
biomarkers neurohormonal stimulation inflammation endothelial_ dysfunction
medical management heart_ failure Canadian_ Cardiovascular_ Society
Neurohormonal abnormalités pathophysiology congestive_ heart_ failure chf
Heart_ Failure Pathophysiology Medical Treatment Nursing management
parasympathetic_ neurotransmission acetylcholinesterase
end-stage_ renal disease outpatients systolique_ heart_ failure
anemia heart_ disease American_ College_de_physiques
renal DNx cardiac_ autonomic balance CHF sympathetic_ tone
ventricleRV cardiac_fonctionnel
radiological signs hf
congestive_ heart_ failure chf
mri scanner heart
Jehovah_s Witness sickle_cell_ disease anemia
chromatin_subproteome mouse heart
Mediterranean DASh mortality women heart_ failure Womens_ Health Initiative
currents rad congestive_ heart_ failure
cardiopulmonary_ exercise heart_ failure
morbidité mortalityHF
costs heart_ failureHF
muscle-wasting_ syndrome acquired_ heart_ failure Fontan
miRNAs heart_ failure
Health_ Buddy_ Program content-driven_ telehealth
resistin anthracycline-treated breast cancer cardiotoxicity
dobutamine furosemide oxygen
therapeutic heart_ failure
Mortality aCS consultation
cPCs diabetes
LVEF long-terme mortality
Health_ Buddy_ Program ED
inhospital_ mortality bNP mortality
ctnt NT-probNP hz
RV_ dysfonction weight_ loss fat
futility data monitoring board
MT consultation abdominal
complication
mortalité

ejection_fraction cardiac_resynchronization_therapy heart_ failure
biventricular_pacing left_ heart_ twist porcine right_ heart_ failure
Stress doppler echocardiography pulmonary_ hypertension
aortic_ valve ventricular implantation
ventricular ejection_ time acute_ heart_ failure precapillary_ pulmonary hypertension
myocardial_ diastolique_ dysfunctionDD collagen_deposition
septal wall avd free wall VVD
etiologic causes RV ventricular_ dysfunction
pulmonary artery
confidence intervals cs
strain echocardiography ablation
HR_reduction beta_blockers hf

cPCs functional_ capacity heart_ failureHF
transplantation circulatory_assist device
i-mig myocardial
circulation_progenitor_cells heart_ failure
systolic diastolique_metral leaflet organic lesion
inhibition protein_ kinase guanylate_ cyclase contractile
beta_blockers mortality heart_ failure
p refractory end-stage_congestive_ heart_ failure chf
perioperative
trastuzumab cardiac
économique af heart_ failure Québec
insurance_status
st2
cardiac_ Mena deletion cardiac_ dysfunction abnormalités hypertrophy
bundle-branch_ blockLBBBLBBB
CHF atrial explants sham explants
hf valve_ plasty ms mva
NYha
pressure_ ulcers surgical
Timed_up_go organ_ failure
Nursing-sensitive_ outcome_changes
chelation heart
transcatheter surgery
black_ race mortalité
social_support
resistin chemotherapy-induced heart_ failure
therapeutic_fonctions fluid_Overload
nursing hospitalized hf
heart_ failure
echocardiographic invasive_ hemodynamic
right_ atrium_ mass prolapse tricuspid valve stenotic_ physiology
apoptosis pacing-induce dilated_ cardiomyopathy
preoperative_serum_albumin ventricular implantation
INVESTIGAtions cardiac_ catheterization thrombotic_ obstruction right_ coronary_ artery
Western_ blots monoclonal antibodies Ser83 phosphorylationHF
Fontan_ failure systolique_ventricular_fonctionnement liver
functional_capacité mwt
Chinese_ herbal medicine dilated_ cardiomyopathy heart_ failure
chronic_ heart_ failure chf sympathetic_ tone autonomic_ imbalance
implantable cardioverter-de_fibrillator_deactivation
electromechanical_delay dyssynchronous_ heart_ failure
EH cardiac_ filling_tensions
hff dietary_sodium ventricular
Heart_ failure mortalité society cardiovascular
proteins Western_ blot DNA_ fragmentation tunel autopsy
magnetically_ Levitated ventricular_ Assist HF
neurological cardiovascular
heart_ failure
hf
MADit-cRT
chemical instability cogeneration_de_ nitrite
Czech Republic
BETs TAC hz
dopamine nesiritide
UM/vava-RT
transfusion mortality
consultations
cardiac nurses
closure
cost-effective
California office_of_ State_wide_ Health_planning_et_ Development Patient Discharge
extracorporeal_ membrane oxygenation infarction-related refractory_ right_ heart_ failure
anticoagulation therapy heart disease
temps-varying Seattle Heart_ Failure
Paco2 cerebral_ blood_ flow carotid
pathophysiology hf medical management
ed physicians suburban_hospitals New_ Jersey New York
heart_ failure protein_ kinase expression
cox_regression cardiovascular events psoriasis
énergie_ metabolism heart_ failure hypertrophied_ heart
echocardiography shunt implantation
inotropic effect beta_blockers heart_ failure
mechanical_ cardiac_support renal
ECmo VAD ECmo
functional MS LV dilatation functional MS
NT-probNP circulation HF
mortalité morbidité cancers budget
NT-probNP
HDl production flow-mediated_dilatation ET
systolique_fonctionnel
aHF
PAD ankle-brachial index
class_ iccp
HR ivabradineTAC
TM sts
HRQoL
Reasons
readmissions hospital rankings pay-for-performance
iCD
hf

ventricular_assist device extracorporeal_ membrane oxygenation renal_fonctionnel heart_ failure
Cardiorespiratory_ fitness body_ Mass_ index heart_ failure Cooper Center_longitudinal_ Study
cox models ST2 functional_capacité
New York_ Heart_association
Exercise_intolerance heart_ failure
m-proadmffm
vasopressin_ receptor_ antagonist tolvaptan Japanese heart_ failure
functional MS ring_ annuloplasty ischemic MR LV
bNP NT-probNP biomarkers heart_ failure
psoriasis smoked diastolique_ blood_tension
interleukin_ receptor ST2 beta-blocker therapy heart_ failure
hf cardiac_ murmurs blood_tension hg
biventricular_ dysfunction HeartMate
renal_ dysfunction mechanical_ cardiac_support
ventricular_assist devices device_therapies
Functional MS medical
ventricular_dislatation
anemia heart_ disease
heart_ failure systolique_ heart_ failure
hf v beat-to-beat QT
isoproterenol cXL-1020 myocytes hearts
implanted
PB hf
tug tests COPd CHF cRF
Heart_ failureHF
rhythm-control rate-control
HF health service_ provisionHF
hemoglobin
heart_ failureHF

CF lVAD AI heart_ failure
cfa
hemodynamically_ unstable cPR
Nursing social mandate
physical activity cardiovascular_risks diabetes mellitus hypertension hyperlipidaemia


sudden_ cardiac death
hospital_ mortality
administration trastuzumab CHF
rehospitalization
hospitals
biomarker-guided_ clinical
medical records
Circulation natriuretic_peptides heart_ failure
heart_ failureHF ventricular_ ejection_fraction hpEF
Pyridostigmine myocyte collagen_density ventricle
cardiac_ angiogenesis coronary_perfusion cardiac_ fibrosis
implantable_ cardiac_de_fibrillator
adenylyl_ cyclase g-protein_ coupling
heart_ failure ventricular_tachycardia
pressure-overload-induce heart_ failure
Exercise_intolerance hff
systolic_HF unclear_ etiology coronary_ angiography
Heart_ failureHF sympathetic_ activity parasympathetic_control heart
ATP demand ros mitochondrial_ respiration contractile
end-stage_ heart_ failure implantation ventricular_assist device
atrial_ fibrillation congestive heart_ failure rhythm-control rate-control
ejection_fraction ef infarct growth myocardial_perfusion
HR tNF nbDMARD
surgical_revascularization catheter-based
Morpholino-based knockdown nucleolin protein expression
bNPPAD bNP hz
CVd psoriasis
population-based Rotterdam psoriasis cardiovascular
race hf
hpEF
parasympathetic_fonctionnel HF
diabetes_ mellitus cardiovascular
clinical_ prediction rule CAD systolicHF
cognitive_ impairment mortalité
SCHf
ECmo egFR egFR
haemodynamic pulmonary
prediction_ rule
CAD
HF-related cachexia RV
acute_HF
hgb kccq
General_hospital cardiac_specialty_hospital rural South_dakota
aCS MT VAD
sonographic histological functional abnormalités gastrointestinal
energie_ substrate_ metabolism working_ hearts aac
jugular_venous_tension peripheral_ oedema
Spironolactone hyperkalemia acute_ kidney injury
heart_ transplantationsLV implantations heart_ failure
functional_metral_ stenosis ring_ annuloplasty ischemic_ mitral_regurgitation
anticoagulants antiplatelet drugs heart_ failure atrial_ fibrillation
mechanical_ cardiac_support renal_fonctionnement end-stage_ heart_ failure
natriuretic_peptide biomarkers point_de_care poc
Heart_ failureHF condition
EH systolique_ blood_tension renal impairment hypertension
pump-exchange technique redo sternotomy cardiopulmonary_ bypass
chronic_ myocardial_ischemia heart_ failure
mouse HF transition LV hypertrophy hd
MS HF functional MS
sympathetic parasympathetic_ activity hf
hf ms mva
heart_ failure ejection_fraction doppler echocardiography

cardiovascular conditions hf
health_ insurance health_système Food_en_ Drug Administration
général abnormalités heart
Raf-MEK
albumin lVAD
HeartMate_ II lVAD
Bisphosphonate heart_ failure
sustainability commissioning hospital-commune-based
HF-induced remodeling EMd
early-onset MI late-onset MIHF
costs
maladaptive_ molecular
patient_ safety
Xanthine_ oxidase ventricular_synchron diastolique cardiac
ventricular_ longitudinal_ systolique cardiovascular events atrial_ fibrillation
Heart_ failure medicine atheromatous_ coronary_ disease
medications heart_ failure NCDR_ PINnaCLE
unloading_de_la_ heart HR systolique_ heart_ failure
hpEF medical
hpEF breathlessness fatigue fluid_retention
circulating mediator_de_ insulin_ resistance
NT-probNP ed patients acute_ heart_ failure
aortic_ valve surgery new-onset lVAD
Nordic_ walking cardiac rehabilitation
spironolactone systolique_ heart_ failure
réseau Cytoscape functional_enrichment DAVID
Blacks hypertension diabetes ischemic_ etiology socioeconomic status
immunodetection NT-probNP antibodies
Fontan_ circulation sVR cardiac
mineralocorticoid
rehospitalization medicare fee-for-service
palliative
hf cthazard
lVAD
oxidative stress GTPase_ Rac1 activity hearts
Fontan_ circulation skeletal_ muscle_ mass metabolic
right_ heart_ circulation right_ heart_ failure
Heart_ failure hz Latin America la health_service_ planning hz
p therapy hf
transformed

heart_ failureHF Heart_ Failure
adrenergic_ receptor_blockade heart_ failureHF
Myocardial_ infarction left_ anterior descending coronary_ artery
ventricle_overload stroke ventricular_ ejection_ time lVET
nonselective beta-blockers cardiac_mécanique_ activity hemostasis heart_ failure
cardiovascular_ death urgent_ cardiac transplant
Chromatin-associated proteins chromatin_ structure DNA
diastolique_ dysfunction hff
β-Blockade cardiac_ angiogenesis heart_ failure VEGF
NT-probNP hz immunoprecipitation
parasympathetic tone pyridostigmine ventricular_ dysfunction heart_ failure
myocardial_ischemic events cardiac_resynchronization_therapy
HF ejection_fraction hpEF hypertension
NYha_fonctionnel class quality-of-life
dégs non-ischemic ischemic heart_ failure
RV_ dysfonction weight_ loss body_ composition hz
angle_ failure Emergency_ Department ed ed ED
gut inflammation heart_ failure
CHF ed intubated
robot-assisted gait_therapy Lokomat_system heart_ failure
therapeutic exercise hemodynamic

lVET death ICU
readmission
Intravenous_ iron heart_ failure iron
pp acr CMS
mortalityLCx LAD two-vessel disease
stress conditions remodelling heart_ failure
psoriasisUV
congestive_ heart_ failure
Beta-blocker
pulmonary_hytensionPH heart_ failure
nations_white_ rabbits renal DNx pacing-induced CHF
mutant_mice heart_ muscles pathological_ hypertrophy
dialysis
heart_ failure ejection_fraction
QT_ variability qTV QTV cardiac_ death
mitochondrial structure sarcomeric_microstructure
consenting ambulatory HF ventricular ejection_fraction
hz CHF-NYha-IIIb HDL
aim implantable cardioverter-defibrillator
microRNAsmiRNAs heart_ failure
uptitration heart_ rate renal_fonctionnement spironolactone
CHF therapeutic_ interruption neurohormonal
physician_ follow-up_ after_discharge death readmission heart_ failure
catheter ablation antiarrhythmic drugs rhythm_control_therapy
poc technologie
cardiac_ dysfonction subcellular metoprolol heart_ failure myocardial_ infarction
Cardiac_ magnetic_ resonance heart_ failure ejection_fraction
LV diastolic_ dysfonction filling_tensions doppler_echocardiography
heart_ magnetic_ resonance_ imaging chelation_ choices heart_ disease thalassaemia
Myocardial collagen collagen
mri respiration myocardial swine heart_ failure
RAS-blocker_uptitration hFrEFHFpEF
Systems_protecomics cardiac_ chromatin nucleolin corruption cardiomyocytes
Cardiac_ failure diabetes heart_ failure
zf rats heart_ failure ejection_fraction
Hemoglobin cardiovascular_ failureHF-action
PARADIGm-HF chronic_ heart_ failure heart_ failure cardiology
arterial_ tonometry VET precapillary_ PH heart_ failure
transoesophageal_ echocardiography shunts thrombosis migration
Cross-talk heart adipose_ tissue cachectic_ heart_ failure
readmissions
cardiovascular_ disease
financiers hospital_ rates h patients CMS conditions
septal
psoriasis cardiovascular_ diseaseCVd
aCS problems oHT transplant MTVAD
beta-blocker
validité coût
hospital AMI mortality
proteins
Plasma hf
index_admission index_admission
medical management hf
Rhythm_control_therapy
therapy
cardiovascular_ disease dRS
heart_ failure CLCNka_sNP
miRNAs cardiac_ remodeling heart_ failure
sandwich Alphalisa immunoassas NT-probNP
hf rheumatoid_ arthritisRA
transduction_ pathways signalling_ proteins
clinical_ diastolique_ dysfunction cause_ mortalité
regulation_de_ feeding nutritional anti-inflammatory effects CHF
pde2-overexpressing cardiomyocytes norepinephrine hypertrophic
alendronate
frailty heart_ failureHF
expression Bax bcl-2 proteins
RAS- β-blocker
GDMT GDMT BAT
heart_ failure bisphosphonates
hz
Blocker cardiac_ angiogenesis therapy cardiac_fonctionnel
nicorandil cytotoxic effect doxorubicin Ehrlich_carcinoma
death c-statistics biological_ phenotype deficit
Myxomas cardiac_ benign tumors
natriuretic_peptides
LV diastolique_ dysfonction hff
Renal_denervation dx CHF
implantable cardioverter-defibrillator_de_activation
FontanSAF catheterization
heart_ failure left_ventricularLV ejection_fraction
ambulatory iCD mortality multivariable_regression
sinus rhythm antiplatelet agents anticoagulants
physician_ follow-up_ after_discharge physician_continuité heart_ failure
MT VAD aCS mortalité morbidité
cardiotoxicité doxorubicin anti-neoplastic
Fes preserved_ ejection_fraction hpEF
lifesaving drugsHF ejection_fraction hrEF
refractory_congestive_heart_ failure peritoneal_ dialysis
ICU_ admission precapillary_ PH heart_ failure
Myocardial loss iRS1 iRS2 heart_ failure MAPK insulin_ resistance
ARNI inhibitorsangiotens-receptor_ neprilysin
Functional_metral_ stenosis m ring_ annuloplasty ischemic_ mitral_regurgitationMR
heart_ failure ejection_fraction hff
Heart_ failure ejection_fraction hff cardiovascular_ reserve
leanzf1 obese ZSF1 diabetic
Mammalian_ enabled mena cytoskeletal_actin_ dynamics heart_ failureHF
Gastrointestinal_ bleeding ventricular_assist devices
heart_ failure ventricular_ ejection_fraction
myocardial pde intracellular antiadrenergic hz
bNP NT-probNP coronary_ artery_ diseaseCAD
heart_ failure left_ atrial_tension hospital_admission
hyperkalemia kidney injury spironolactone
Heart_ failure ejection_fraction hpEF cardiovascular_ morbidity mortality
eCG cRT
NT-probNP
transfusions heart_ disease
benefits spironolactone
VO2 joint effect
HFHF
sst2 cardiovascular
breast_ cancers trastuzumb CHF
PVf pp BP

ECt
aerobic_ capacity left-hand_ grip_ strength body_ weight waist_ circumference anxiety
Process_redesign
doppler_ imaging left ventricular filling_tension systolique_ heart_ failure
heart_ failure hypertensive_ heart_ disease angiotensin infusion nephrectomy salt loading
Kansas_ City Cardiomyopathy Questionnaire heart_ failure ejection_fraction
anemic iron-deficient heart
heart_ failure hospitalisation elderly
trastuzumab CHF nontrastuzumab
HR beta-blocker
coronary_ occlusion collateral_ growth stent_ occlusion
psoriasis disease atherosclerosis cardiovascular events psoriasis
carotid_ intima-media_ thickness psoriasis
pde2 failing hearts acute β-AR
Mechanical_ dyssynchrony QRs cRT
Remote_ monitoringRM heart_ failure
ie heart_ failure hz ct-d
RV dysfunction cardiac_ cachexia
egf diuretics hypertension ESRD
chronic_ heart_ failure Hungary
pharmacologic treatment pharmacologic
point-of-cares NP ed outpatients acute_ heart_ failure
Renal_ dysfunction mortalité cardiovascular events caBG
arterial_ complianceTAC end-systolique_ elastance ees
Renal_ dysfonction long-terme mortalité myocardial infarction coronary_ artery_ bypass grafting caBG
cardiovascular_risk factors diabetes_ mellitus atrial_ fibrillation coronary_ artery_ disease hpEF
coronary_ artery disease systolique_ heart_ failure unclear etiology
Genetic_ susceptibility anthracycline congestive_heart_ failure haematopoietique_cell transplantation
Biventricular support HeartMate_ II_ lVAD CentriMag_rVAD mortality hospital_discharge
e-cFUs mortalité
heart_ failure ejection_fraction myocardial_ infarction
isoprenaline_ infusion SDQT hnormHF
angiogenes post-myocardial_ infarction heart_ failure
aldosterone_ antagonist heart_ failure
acute_ heart_ failure hz
surgery hf hypertension vasodilateurs diuretics
HF remodeling EMd dyssynchronous_ failing_ heart
Shunt implants transseptal catheterisation transoesophageal echocardiographic
dopamine nesiritide
hff
MEDLINE eEMBAse clinical_ trial
egf VAD edmo VAD ECmo
black_ race hf cardiovascular_ mortality
biomedical reasons
Clinicion
HFHF
Care management content-driven_ telehealth technologie health_ outcomes high-cost Medicare
lVAS
ERC epicatechin
Ea TAC HR ees ivabradine
physician_ adherence HF_cPGs
hf hf mortality
HDl_fonctionnel CHF HDl-mediated_ vascular
Pyridostigmine vascular_endothelial_ growth_factor_ protein left ventricle myocardial_ angiogenesis
idiopathic_ dilated_ cardiomyopathy
proteomics chromatin-associated
tNF antagonists h hospital_admissions nbDMARDs RA
pharmacologic management hf
HeartMate_ II implantation
RV_ dysfunction body_ mass_ index fat_ mass_ index cachexia
therapy atrial_ fibrillation carvedilol metoprolol
cf HF mortality HF
CHF Diseases codes
exercise health_ benefits cardiac_ disease heart_ failure
converts hno inactive cXL-1051
myocardium expression pKA
cardiac_ growth plasticity disease chromatin remodeling
elastic_n2Bus PEvk
Robot-assisted_ gait_therapy Lokomat_system heart_ failure
Nicorandil mitochondrial_ dysfunction doxorubicin-induce heart_ failure
RAS hypertension nephropathy congestive_ heart_ failure
brain natriuretic_peptide bNP creatinine natremia
heart_ failure mechanical_support devices Cardiology-cardiovascular_surgery Heart_ failure
Heart_ rate_reduction exercise heart_ failure ejection_fraction beta-blocker
SDQT SD RR rte QTV heart_réquence
Self-Care_of_ Heart_ Failure figure
Isoelectric focusing RIα Ser77 Ser83 phosphorylation
functional MS valve plasty MR LV
management_ end_ stage_heart_ failure Heart_ failure public_ health_problem europe
st-segment-elevation MIs Killip conditions
myocardial_ infarction m heart_ failureHF
arterial_ elastance resistive pulsatile heart pressure
NT-probNP MR-proanp MR-proadm
heart_ failure implantable cardioverter-de_fibrillator
HeartMate left_ventricular_assist_system lVAS heart_ failure
hf PAf biosynthetic_ enzymes lyso-paf-AT
sst2/low-dose BB sst
hf complicating AMI mortality
zebrafish nucleolin genomic_reprogramming
ms cardiac events
LV ejection_fraction PCWP hg
CHF ED visits CHF patients intubated
grs h CV
egf VAD edmo VAD renal_fonctionnement
Physician_ volume mortality hf noncardiologist
ejection_fraction
mortalité hospitals

nurses magnet
physician
mADIt-cRT multicenter_automatic_ Defibrillator implantation Cardiac_resynchronization Therapy
cardiac_ magnetic_ resonance_ imaging mapping invasive_ hemodynamics
Morbidité mortality hpEF hf EF
Logistic_regression
iron exercise heart_ failure
emergency_ department acute_ heart_ failure
molecular biomarkers pathophysiology hf
knockdown BET bromodomain-containing_ proteinBRd
readmission hospital_ stay congestive_ heart_ failure
aUCs eseptalseptal QRs
heart_ failureHF inpatient
diureticsHF
IVc occlusion co correlated twist apical rotation RS synchrony
carvedilol metoprolol heart_ failure devices
gastrointestinal_ bleeding
readmission_ rate patients_contre_heart_ failure
public_ health air pollution
Medicare inpatient h admissions acute_care hospitals
respiration gadolinium-chelate
HFheart_ failure t2d diabetes Skm skeletal_ muscle
catheter ablation atrial_ fibrillation heart_ failure ejection_fraction
dopamine nesiritide acute_ heart_ failure renal_ dysfunction ROse acute_ heart_ failure
cardiopulmonary_ exercise quality_of_ life muscular_ strength quadriceps force
DAPcdystrophin-associated_ protein_ complex sarcomeric
hz pyridostigmine basal_ heart_ rate vagal sympathetic_control_de_ heart_ rate
eCG ion_ channelopathies cardiomyopathy
RAS neprilysin_ inhibition chronic_ heart_ failure systolic_ dysfunction
mouse hh hd salt loading uninephrectomy ANG_ II infusion
Benefits HF ejection_fraction pEF
in-trial resource_ utilization coût Québec_ Health_ Insurance Board disease-specific costs Ontario Case_ Costing Initiative
idiopathic_ dilated_ cardiomyopathy tuscany evidence-based management
Erythropoiesis-stimulating agents anemia heart
mitral valve plasty mitral_regurgitation
Myocardial titin hypophosphorylation heart_ failure ejection_fraction rat metabolic
hpEF kccq
hf MI ejection_fractionEF
pp weight_ loss diuretic edema functional
serum_ creatinine serum_ potassium
rv ventricular_ dysfunction
Mortality inpatient_admissions emergency_ department ed
Chronic_ heart_ failure transforming_ growth_factor_ beta-dependent decline atrial implant-derived c-Kit
anemia chronic_ heart_ failureHF
HeartMate_ II_ lVAD CentriMag_rVAD
readmission
echocardiographic score ct
économique models mandatory lVAD
ejection_fraction
AF ablation
Cardiac insulin-resistance mitochondrial_énergie heart_ failure pressure-overload hypertrophy
If-channel_ inhibition hemodynamic heart_ failure ejection_fraction
heart_ failure heart_ failure cardiology services mortality
PAf metabolic_ enzymes heart_ failure
Phosphodiesterase-2 failing hearts beta-adrenergic cardiomyocytes
trastuzumab cardiotoxicity congestive_ heart_ failure chf
myosin binding protein-c phosphorylation troponin phosphorylationHF
preoperative_ renal_ dysfunction stroke myocardial_ infarction heart_ failure caBG
pyridostigmine administration methylatropine propranolol cardiac
echocardiographic cardiac_resynchronization_therapy cRT
chromatin_subproteomes heart_ failure proteins
NT-probNP antibodies
Hum-retn mice cardiac mRNA inflammatory cell_adhesion Retn
nbDMARD tNF
end-stage_heart_ failure pediatric mechanical_ cardiac
hf hf exercise hz beta-blocker therapy
avantages implantation heart_ failure
cox hazard models temps ESRD end_point_de_ ESRD death ESRD

rheumatic MS mva
pigs inferior_vena_cava icc co
doxorubicin induction serum_ resistin Hum-retn mice
nutritional_ abnormalités CHF fat carbohydrates
costs high-volume physicians
deactivation
University_of_connecticut Heart_ Failure Center cardiologist heart_ failure
aldosterone_ receptor_ antagonists morbidity mortality systolique_ heart_ failure
XO inhibition cardiomyocyte_ bioenergetics LV aCF
ecardiographics pro-brain natriuretic_peptide inflammatory
hf rats pyridostigmine stroke ejection_fraction cardiac_ output contractility ventricle
carvedilol thromboembolic events heart_ failure β2-receptor_haplotype
uPR protein_ kinase ER kinaseperk calreticulin CHOp hz
heart_ failureHF cardiopulmonary_ exercise anaerobic
randomised-controlled trialsrcs
therapeutic biomarkers molecular_ dysfunction h
CV_ deaths non-fatal_ stroke heart_ failure
CAD
medical hospitalizationHF
sCN5a uPR downregulation cardiac_ genes HF
eAST rhythm_control_therapy af cardiovascular complications AF
air pollution cardiovascular_ health acute_ myocardial_ infarction
économique_ climate NHs behavioural-change chronic_ disease
cardiac_ deaths atherosclerotic CAD
dialysis-dependent patientsHF cRT implantation complications
Peak_ oxygen_ consumption oxygen_ pulse
RV pathophysiologic mécanismes RV
post-hct CHF hct City_de_ Hope
Womens_ Health_ Initiative hf
VAD ECmo VAD ECmo
albumin nutrition inflammation hepatic implantation
ventricularRV insertion left ventricular_assist device lVAD
neurohumoral blockersHF co-morbidity_ burden
risk c statistic discrimination
AMI heart_ failure kidney infectionUTI
hazards
Testosterone therapy exercise_ rehabilitation heart_ failure testosterone
odds_hazard HFAMI discharge
passage PASp
kccq Kaplan-meier curves
mAIN_ oUTCOME grs index_ beat cox
lipolysis énergie_ expenditure natriuretic_peptidesNPs CC
ischemic heart_ failure biomarkers heart_ failure
CHF infarcted animals ventricle_ end-diastolique_tension hg scar
Olmsted County Minnesota MIHF
hearts Mena cardiac_ injury Mena HF
RAS doppler_ ultrasonography tomographic_angiography magnetic_ resonance_angiography
lVAD transplantation budget

ct-d IE therapy
icc multicenter_automatic_ Defibrillator implantation Trial-Cardiac_resynchronization Therapy
Health_ Buddy Program chronic_ obstructive_ pulmonary disease mortality congestive_ heart_ failure
Cardionnaire_ exercise echocardiographic myocardial_fonctionnel ventricular filling
echocardiography ste BiVP ventricular_tensionRVPO
hypoalbuminemia postoperative mortality left ventricular_assist_ device lVAD implantation
inhibition vascular_endothelial_ growth_factor vf transition compensatory_ hypertrophy cardiac_ failure
ventricular ejection_fraction heart_ failure Heart_ Failure ISrael
obesité diabetes_ mellitus metabolic_risks heart_ failure ejection_fraction
nicorandil cardioprotection apoptotic signaling_ pathway DNA fragmentation mitochondrial
percutaneous_ coronary_revascularization hemodynamically
therapy atrial_ fibrillation atrial_tachyarrhythmias ATP shock therapy
pathophysiologic mechanism renal_ underperfusion renin- angiotensin-aldosterone
proteomics pressure-overload-induce heart_ failure mitochondrial-targeted
hz
av_mice LV fractional_ shortening lung_ weight
functional_enrichment programmed_cell_ death degs
dysfonction rad_variant kv congestive_ heart_ failure
PERK mRNA channel mRNA splice
systolique_ heart_ failure spironolactone
eCG atherosclerotic CAD cardiac_ death
HR dynamics temps-domain HR variabilité risk
sex EF bNP hf bNP
hf index_AMI mortalité
BETs transcriptional_ pause_ release transcription pathological_ stress
apoptosis heart_ failure
diuretic_ efficacy neurohormonal_ activation fluid_overload
uPR channel_mRNA splice cardiac hz
LVEF LVEF
Mena expression hf Mena cardiac_ pathophysiology
pp poc ps
RECENT_financiers intestinal morphologie permeability absorption_fonctionnel CHF
benefits
fibrosis heart_ failure ventricular_ tissue trichrome_ blue histologic
annular_ plane_ systolique_excursion pulmonary arterial_ systolique_tension heart_ failure ventricular_contractile
atrial_fréquence atrial_fréquence
Kansas_ City Cardiomyopathy_ Questionnaire kccq hf hpEF
Trastuzumab CHF nontrastuzumab
Blood_tension arm_cuff stroke ejection_fraction end-diastolique echocardiography
atrial_ fibrillationAF heart_ failureHF stroke
salt loading uninephrectomy ANG infusion cardiac
bottleneck stent myocardial_ infarction antiplatelet
LVEF mortality hospitalization acute_decompensated_HF
echocardiographic score LV reverse_ remodeling
Fontan_ failure circulatory_derangement hemodynamic portal_ hypertension cardiac
biventricular support HeartMate_ II lVAD CentriMag ventricular_assist device rad
hf-action hgb HRQoL kccq
functional MS valve plasty annular_ size_reduction MR LV
figure puissance
pathological remodelling heart cardiac_ hypertrophy hf fibrosis inflammation
idiopathic_ dilated_ cardiomyopathy
functional MS valve plasty MR LV
fréquence heart_ failureHF biological_ phenotype
high-volume physicians readmission
EO-cFUs CD34 vf mortality
etiology comorbidities
ARNI cardiovascular_ mortality hospitalization heart_ failure
right_ventricularRV body_commune heart_ failureHF
myocardial DD muscle_ strip_ stiffness titin hypophosphorylation
cardiac_ hypertrophy failure proteins nucleolin
hf
anaerobic metabolism respiratory

coûts coût-effectiveness
cardiac_ magnetic_ resonance amyloidotic_ pattern multiple_ myeloma osteomedullary biopsy
DASh ventricular-arterial coupling hypertensive heart_ failure ejection_fraction
Vascular_endothelial_ growth_factor_blockade beta-blocker therapy cardiac_fonctionnement angiogenesis remodeling heart_ failure
implantable implantable_ cardioverter-de_fibrillateurs ids cardiac_resynchronization_therapy cRT
hpEF echo-doppler_cardiography invasive_haemodynamic assessment
RAS- β-blocker hffHFpEF hospital_admission
ventricular_assist deviceVAD extracorporeal_ membrane_ oxygenation emo renal
American_ College_de_ CardiologyAmerican_ Heart_association RAS
LV remodeling diastolic properties XO_ inhibition heart_ failure
contractile_fonctionnement LV dilatation end-diastolic pressurewall_ stress lung
Circulation_progenitor_cells cps endothelial_ repair cardiovascular
implantable implantable_ cardioverter-de_fibrillator_de_activation heart_ failure
NT-probNP plasma dyspnea ventricular_ dysfunction ED
Caucasian p rs10927887 renal_ chloride channel_général cCNka
Physician volume medically_ managed diseasesHF
frail
LBBB implantable_ cardioverter_de_fibrillator-cRT
RM discharged heart_ failure
exercise-induced PASp hg PASp
eplerenone HF-ref hyperkalemia WRF
t1-mapping technique diffuse_ myocardial changes heart_ failure contrast agent breath-holding
bt dt coût-effectiveness bt
hff
expenditure health gross_national_ income h
af pharmaceuticals hff
is ct-d heart_ failure
SDQT HFVT hnorm fixed-rate_atrial_pacing
bp inhospital_ mortality
blood_tension lipid-lowering therapy smoking RAS
QRs morphologie cardiac_resynchronization_therapy cRT
mitochondrial_ complex_ V activity aac phosphocreatine ATP
Yorkshire_ swine implanted pacemakers ventricularly_ paced heart_ failure
mortalité heart_ failureHF implantable_ cardioverter_de_fibrillateurs ids
Cardiovascular Outcomes Renal_ Atherosclerotic_ Lesions coRAL stentingRAS
MI animals metoprolol plasma_norepinephrine dopamine epinephrine
cardioprotective_ signaling myocardium biomarker heart_ failureHF
skeletal_ muscle_ sarcomere_ structure heart_ failure diabetes epicatechin-rich cocoa
embryonic_ genes pathological_ heart disease transcription factors
heart_ rateHR ivabradine systolique_ heart_ failure
mdc change
acute_ heart_ failure aHF
multiparametric_ echocardiographic score reverse_ remodeling cRT
biomedical treatment chm biomedical treatment dCM heart_ failure
centrifugal_fréquence_pump hemocompatibility magnetically levitated rotor blood-flow
sst fréquence cardiovascular events
Mediterranean Dietary_Approaches_ to_ Stop_ HypertensionDASh mortality postmenopausal_ womenHF
POc pNP
life functional_puissance
echocardiography cardiac_ diameters cardiac_fonctionnement b-treated
LBBB QRs implantable cardioverter_de_fibrillator-cRT
mortality readmissions costs
MEDLINEEMBAse PsycINFO

therapeutic left-to-right interatrial_ shunting heart_ failure ejection_fraction
systolic HF cXL_-1020 left heart filling_tensions systèmeic_ vascular_ resistance cardiac stroke
heart_ failure hypertension mitral_regurgitation mitral_ stenosis heart_ failure
PERK activation sCN5a kv mRNAs transient receptor mdp mRNA
implantable_ cardioverter-debrillator Heart_ Function_ Clinic University_ Health_ NetworkToronto
cardiovascular_ death stroke heart_ failure myocardial_ infarction
Exercise-induced PASp pulmonary_ hypertension ventricular_contractile
antagonists inhibiteurs renin-angiotensin-aldosterone sympathetic_ nervous_système CHF
Cardiac-resynchronization_therapy ct morbidity mortality chronic_ systolique_ heart_ failure QRs
truncated na_ channels unfolded_ protein response uPR electric remodeling hz
international_ Right_ Heart_ Foundation defects right_ heart_ failure
changes myofiber dynamics myofiber emd dyssynchronous_HF
crude ankle-brachial index pulse-wave_ velocity coronary_ artery_ calcium
allopurinol contractile_fonctionnement XO-mediated ROS myofilament
antiplatelet agents anticoagulants
Mice cardiac_ hypertrophy pressure-overload abdominal_aortic_constriction aac
HF hf epidemiologie SH cd rheumatic_ fever
medications heart_ failure ejection_fraction
caloric restrictiondiet aerobic exercise_training exercise_puissance QOL hf
chronic_ heart_ failureHF hemodynamic_ disorder dysfunction interconnected_ molecular
hpEF diastolic filling temps heart_ rate
kccq hgb HRQol
heart_ failure hospital_discharge readmissions
mice cardiac_ myocyte Mena_ overexpression tgtetMena cardiac
Fontan_ failure hemodynamically heart_ failure systèmeic_ vascular_ resistance sVR cardiac
implanted_heart_ transplant ECt

metabolic exercise cardiac kidney index
heart_ failure etidronate alendronate
physicians advanced_ heart_ failure
af heart_ failure financial burden
therapy comorbidities
ET HDl-mediated_protecive_ effects molecular pathways chronic_ heart_ failure chf
rehospitalization Medicare hospital_ claims Medicare post-acute_care_transfer_policy
physical activity cRF HF mortality
body_ weight FMffcc
intermacs interagency_ Registry_for_ Mechanical_assisted_ Circulatory_ Support
eccentric ventricular hypertrophy heart_ failure ejection_fraction
ventricular ejection_fraction heart_ failure preserved ejection_fraction hpEF
ventricular ejection_fraction ventricular_ diastolique_ end_ diameter
β-adrenergic receptor_blocker therapy myocardial_perfusion neoangiogenesis heart
extracellular_ matrix left ventricular biopsies tissueFAXs technologie
hART hf hf hf reduced_ ejection_fraction hrEF
conscious dogs tachypacing-induced hz contractility end-systolic elastance venoarterial dilation
actin_ cytoskeleton mitochondrial metabolism glycolysisgluconeogenesis citrate
resistin anthracycline-induced_ cardiotoxicity heart_ failure
bone_ morphogenetic_ protein expression rRNA transcription
ventricular_assist devices lVADs heart_ failure pump_ dysfunction pump
sCN5a angII hypoxia uPR
fréquence hz mortality hazard mortalité
hyperkalemia hypokalemia spironolactone
bp diastolique_ dysfonctionnement
dopamine nesiritide renal
NT-probNP
g-protein-coupled receptor_ kinase
imaging techniques systolic_fonctionnement hpEF long_axis_fonctionnement
ST2 amino-terminal natriuretic
anemia iron_deficiency MEDLINE cochrane_ Library
change hospitals
creatinine bNP furosemide oxygen_ flow dobutamine norepinephrine
biomedical treatment chm biomedical treatment dCM heart_ failure PubMed
myocardial_ collagen myocardial_delayed_ enhancement_ imaging
sst2/high-dose BB sst2
Sprague-Dawley sham aCF allopurinol
biventricular_pacing biVP cardiac_ output co cardiac_ surgery
saxagliptin sitagliptin
kccq HFpEF robbach
implantable_ cardioverter_de_fibrillator-cRTLBBB QRs
alendronate- etidronate raloxifene-treated
clinical_ trials
HF Danish_ Heart_ Failure_ database new-onset ESRD Danish Registry_ on_Dialysis
Chemotherapy trastuzumab CHF International Classification_of_ Diseases Healthcare Common_ Procedure codes
contemporary_ heart_ failureHF HF ventricular_ ejection_fractionLVEF
ct hazard
transplantation consultation MT consultation
Hospitalized_ Heart_ Failure Saxagliptin sitagliptin antihyperglycemic Drugs
Race heart_ failure Heart_ Failure
correlation_coefficient icc kappa coefficient change mdc
Nicorandil phosphocreatine adenine_ nucleotides mitochondrial oxidative_phosphorylation creatine_ kinase
implantation LV implantation heart_ failure
neurohormones adipokinescc progressive loss fat_ free mass fm fat_ massFM
Swedish_national_inpatient_ Registry rehospitalization stroke myocardial_ infarction heart_ failure caBG
expression mistargeting rad Q66p RGK
catheter_ ablation af hff ventricular ejection_fraction
Myocyte hypertrophy heart_ failure gene expression DNA
magnetically_ levitated lVAS Seattle_ Heart_ Failure
Alphalisa immunoassas antibodies NT-probNP
cardiac_ plasma_ membrane s1PR1 overstimulation heart_ failure
New York_ Heart_associationNYha chronic_ heart_ failure ejection_fraction
biological_ phenotype
tunel apoptotic cells tunel-positive
SDQT ht hnorm β-adrenoceptor_blockade esmolol
surgically_ induced myocardial_ infarction heart_ failure bisoprolol
sts hm medical_support office_ hours all-cause mortality discharged patients heart_ failure
transitions_de_carréquence readmission_ rate congestive_ heart_ failure Midwestern state South_dakota
tachycardia atropine cardiac_vagal_ tone CHF-DNx CHF-inv
cardiomyocytes mechanical humoral stimuli myocardium conditions
passage length-force RV LV
biventricular_support RVADs
functional_ efficacy hno donor myocardial_fonctionnel HF
transitions_de_care
ESRD outpatients systolic hf egf
CHF cardiac_ explant c-Kit
BB therapy avantages sst2 heart_ failure BB
readmission_ rates heart_ failureHF acute_ myocardial_ infarctionAMI pneumonia
heart_ failure ventricular_ ejection spironolactone Kaiser_permanent_ Northern_ California
echocardiographic score LV reverse_ remodeling LV end-systolique
preoperative renal_ dysfunction cardiovascular eventsstroke myocardial_ infarction heart_ failure coronary_ artery_ bypass grafting
aldosterone_ antagonist_therapy heart_ failure post-myocardial_ infarction heart_ failure
left-to-right interatrial_ shunting heart_ failure ejection_fraction
myocardial_ extracellular_ matrix cardiac_ magnetic_ resonance
bmi weight heart rhythm lying blood_tension auscultation valvular disease pulmonary_congestion
Peritoneal_ dialysis p diuretic_ resistant_ volume_ overload heart_ failureHF
Cardiology_practices national_ Cardiovascular_ Disease_ Registry Practice_ Innovation Clinical_ Excellence
hno donor cXL-1020) myoctyes intact hearts heart_ failureHF
peripheral_ muscle_pump cardiac_ filling subpulmonary_ventricle Fontan_ circulation
Nicorandil heart_ rate aortic_ blood_ flow mitochondrial_ oxidative_ stress doxorubicin cardiotoxicity
Renal_ dysfunction heart_ failureHF end-stage_ renal_ disease eRD
heart_ failure preserved_ejection_fraction hff heart_ failure
Peripheral_ artery_ diseasePAD heart_ failureHFHF HFPAD
heart_ failure CHARM candesartan_ in_ Heart_ Failure Mortality Morbidité
FontanPF catheterization
ms subvalvular dynamic annular MS
Lancet anoop Shah air pollution heart_ failure morbidity mortality
cell therapy chronic_ heart_ failure chf explant-derived_progenitor
hff caloric restriction aerobic_ exercise VO2
anemia hf health-related quality_of_ life hQoL hf
mri dyssynchronous_nonfailing h canine_électromechaniques remodeling
HR_ variability mortalityAMI CHFLV
race chronic_ heart_ failureHF
drug-free
cell_ senescence active malignancies cancer prostate osteoporosis depression dementia
histological analysis capillary coronary_perfusion ad-flk rats
shuttle_ walk_test body_ mass hand_ grip_ strength
physician_ volume mortalité interns cardiologists
protocol-driven POc NP consultation ED throughput
Troponin_t natriuretic_peptide biomarker heart_ failure atherosclerosis
RV_ failure chronic pulmonary_ arterial_ hypertension ph pulmonary_émbolism
tachycardic_ response methylatropine vagal_ tone bradycardic_ response propranolol
prilysin natriuretic_peptide breakdown atrial natriuretic_peptide
économique_ Analysis Patient management_ Interventions Heart_ Failure cost-effectiveness disease managements heart_ failure
Fractional_ flow positron_ emission_tomography ischemia bottleneck ventricleLAD
cardiac_resynchronization_therapy cRT heart_ failure hz QRs ejection_fractionEF
mitochondrial oxidative_phosphorylation_puissance creatine_ kinase stress DNA_ fragmentation
ventricular_assist devices cardiac nurses gastrointestinal_ bleeding
spironolactone death hyperkalemia kidney injury
cardiac_ transplant ecc transplant
septum_systolic_ thickness LV posterior_ wall_ thickness LV
BAT n-terminal_pro-brain_ natriuretic_peptide h
American_ College_of_physiques aCP anemia iron_deficiency heart
mortality mortality cardiovascular mortalityHF cox
prospective HF hf ef hpEF
electrical stimulation peripheral_ muscles endothelial_fonctionnel heart_ failure ventricular_ ejection_fraction
SDQT-to-SDr HFVT hnorm
ventricular structure geometry fibersheet
rad Q66p cardiomyopathy channel-dependent
serum_ resistin women anthracycline-containing chemotherapy cardiotoxicity
ss2 cardiovascular
preoperative hypoalbuminemia
renin-angiotensin_system_blocker beta-blocker therapy heart_ failure ventricular
Medical Therapies Cardiac_ Function Breath Lung_congestion
cardioprotective_effet nicorandil hemodynamic_ alterations mitochondrial_ dysfunction doxorubicin
Baroreflex_sensitivity temps heart_ rate_variable hv CHF-inv sham-inv renal DNx
haematopoietic_cell_ transplantation hct congestive_ heart_ failure chf pre-hct anthracyclines
epigenetic_writer proteinshistone_acetyltransferases epigenetic_erasershistone_de_acetylases cardiac
NT-probNP mortality hf
inhibition mir-25 cardiac_ dysfunction murine_ myocardium heart_ failure
electrical_activation dyssynchronous_ heart_ failureHF electromechanical_ behavior heart
nurse cognitive_ impairment physician discharge elderly patients heart_ failure
hypertension hg diabetes_ mellitus
patients_ with_ advanced_heart_ failureheart_team cardiologists cardiovascular surgeons medical
Chinese_ herbal medicine chm dilated_ cardiomyopathy dm heart_ failure
TAPse PASp hff hpEF résolution
rv pulmonary_émbolism mortalité
bisphosphonates alendronate etidronate heart_ failure refill
HF-action hf ejection_fraction
carvedilol β-blocker β-blocker metoprolol thromboembolic events heart_ failure
hm am pna mortality
cardiac_ transplantation ECt
heart_ failure hf hf
remodeling arrhythmia_ substrateAMI HR
hypertension hff DASh rs figure_sodium
EMd dyssynchronous_HF remodeling
ejection_fraction cardiac inotropes inotrope-dependent medical management transplant
doxorubicin-induced cardiotoxicity Hum-retn_mice littermate resistin retn
diastolique_ dysfonction pathophysiology hpEF
8-fluo-cAMP binding phosphomimic Ser77 mutant RIα kd double_mutant
high-density_ lipoproteinHDl endothelial-protective effects endothelial_cell e nitric oxide
dialysisHF hospitalization mortalitéHF
admission_ to_discharge hospitalized_ older adults heart_ failureHF Nursing_outcomes_ Classificationnoc
hf saxagliptin sitagliptin antihyperglycemic agents
albumin mortality lVAD implantation
systolique_ heart_ failure QRs ct mortalité
dgs non-ischemic ischemic heart_ failure
bleeding driveline_ infection gastrointestinal bleeding stroke
cox_regression_ models propensity_ score_decile glucocorticoid HF loop_ diuretics
insulin_ resistance diabetes insulin_ receptor substrates i rs insulin-signaling
dyssynchronous HF electromechanical_delay edd myocyte_depolarization myofiber
Beta_blockers mortality readmissions heart_ failure ejection_fraction hrEF heart_ rateHR
Functional_électrial_stimulation fes exercise emotional stress endothelial_fonctionnel heart_ failure
right_ atrial_ myxoma pulmonary_ arteries right_ atrial_ mass_ removal pulmonary_ embolectomy
transplant_ineligible patients pHF volume_management pre-PD
biomarker studies biomarker-guided_ clinical_ trials multimarker-based
SAF abnormal liver_ textures nodularity
Frailty biological_ phenotype grip strength physical_ exhaustion activity weight
ct-d IE IC ct-d IEs
eds discharge patients heart_ failure ED
QRs morphologie cardiac resynchronization_therapy resynchronization-Defibrillation Ambulatory_ Heart_ Failure_trialRAF
acute_ right_ heart_ failure therapy_refractory_ cardiogenic_ shock heart corporeal_ membrane_ oxygenation emo cPRICU
heart_ disease hz surgical_ palliation
expression Bax bcl-2 mRNA heart_ failure bcl-2/Bax
heart_ magnetic_ resonance_ imaging chelation
nitroxyl hno Angelis salt inotropic lusitropic vasodilator cAMP
ejection_fraction ef pre-PD NYha class_ IIIb ventricular_ dysfunction
cPCs early-outgrowth e-cFUs vEGf
lVADs heartMate HeartWare bt dt
anticoagulation rate_control cardiovascular complicationsstroke cardiovascular_ death acute_ heart_ failure atrial_ fibrillationAF
EF
sexeEF bNP bNP inhospital_ mortality
DASh mortality hf Mediterranean
skeletal_ muscle_ mass lean_ mass
functional_puissance hf
Quality_de_ life all-cause mortality
expression_ profiling cultured_ cardiomyocytes jq1 drug induction phenylephrine-induced
CLca polymorphism heart_ failure glomerular_ filtration reNAStur
cardiovascular diseases heart_ failure hf
cardiac_ VEGF expression Akt endothelial_no_ synthase_activation drug-untreated failing_ hearts
Psychosocial Factors Heart_ Failure Heart_ Failure h-action
heart_ failure ventricular_synchron_ dysfunction BB
coronary_angiography systolic_HF unclear etiology
cardiac insulin-resistance aac insulin-stimulated rates glycolysis glucose_ oxidation plasma_ membrane translocation glucose_transport
angiotensin_ II angII hypoxia activateurs sCN5a mRNA splicing
exercise-induced PASp ventricular_contractile_ reserve
arterial elastance end-systolic elastance ventricular-arterial coupling techniques
post-DASh rs_ brachial blood_tension radial_ arterial_ tonometry cardiovascular_fonctionnel echocardiographic
Gene expression_ profile gse9128 Gene_ Expression_ Omnibus heart_ failure
rhythm_control therapy antiarrhythmic drugs catheter ablation electrocardiographic device rhythm
expenditures noncardiovascular diagnoses implantable cardiac_arrhythmia devices noncardiovascular drugs
HF ejection_fraction hrEF HF ejection_fraction hpEF
extracorporeal_ life_support bridging_therapy acute_ischemic_ right_ heart_ failure refractory_ cardiogenic_ shock reperfusion therapy
heart_ failure left_ventricular_ ejection_fraction fes exercise_ capacity endothelial_fonctionnement hpEF
intubation
hearts ttetMena_mice littermates heart_ Mass transgenic_mice
raloxifene action heart_ failure
hf respiratory_gaz
guideline-recommended drugs heart_ failure biomedical reasons
black_ race hf exercise_ performance hf mortality
Wasting_de_ fat lean_ mass fat_ loss catabolism adipose_ tissue cardioprotectiveHF
lVADs CF HeartMate_ II devices Thoratec_ Corp Pleasanton_ Calif hVAD HeartWare_intl Framingham Mass
hearts_de_ fish_ lacking nucleolin developmental impairment chamber_ patterning functional defects cardiac_ looping myocyte
HF immunoreactive NT-probNP
FM plasma NPs adiponectin FMf NPs adiponectin
Macrophages cardiomyocytes Hum-retn doxorubicin hretn mRNA protein expression
beat-to-beat QT eCGs atrial_pacing esmolol isoprenaline atropine infusion
sympathetic_ tone parasympathetic_ tone heart_ rate metoprolol atropine
EH hpEF pathophysiologically hf hf therapy
acute_méocardial_ infarction congestive_ heart_ failure

change hospital_ quality_ improvement
cardiac_système mice TAC- sham-operated jq1BET pathological_ cardiac_ gene expression
Power low-frequency fréquence hf CHF-inv sham-inv sham
natriuretic_peptideNT-probNP misdiagnosis heart_ failureHF
h-action left ventricular_ ejection_fraction New York_ Heart_association HF
myocardialDD collagen_deposition obese diabetic zSF1 rats heart_ failure ejection_fraction
cardiac_ magnetic_ resonance hff biomarker hff
contractility ventricular-arterial coupling SV ivabradine-treated
conditional_ gene-targeted Hands pressure-overload hypertrophy fibrosis ventricular_ dysfunction fetal
NT-probNP ED acute_HF
clinical_ prediction rule CAD angiography systolic_HF cost
epigenetic readers cardiac_biology cardiac_ gene_control chromatin-dependent signal_transduction abrogate pathological_ gene expressionHF
Systolique_ blood_tension left_ventricularLV hypertrophy
follow-upheart_ failure noncardiac cardiac transplant
catheter-based_percutaneous_revascularization angioplasty stenting
load-corrected chronotropic response heart_ rate
Peak_ oxygen_ consumptionVO2max hz
cox-proportional hazard models negative_binomial_regression models
hf t2d ERC treadmill_ testingVO2max oxygen biopsies
hospital gastrointestinal_ bleeding ventricular_tachycardia storm heart_ failure
β-AR stimulation catecholamine infusions pde2 expression cAMP hydrolytic activity blunted_ cardiac β-AR
HF QRs prolongation LVEF crte reverse_ remodeling LV
chronic pAH RV pharmacologic therapies RV_ failure_management pAH

comanagement clinicians medication
non-frail
frailty Health ABC_short_physique_ Performance Battery hABC Battery Gill HF
RV support lVAD cardiogenic_ shock myocardial_ infarction chronic_decompensation_heart_ failure
Chronic_ heart_ failure chf multisystem_ disease anemia insulin_ resistance autonomic_ dysbalance cardiac_ cachexia
Xanthine_ oxidaseXO rat ventricularLV myocytes mitral_regurgitation aortocaval_fisstula acf
obese Zf1 heart_ failure ejection_fraction lung_ weight ventricular ejection_fraction left_ventricular
high-volume physicians mortality low-volume physicians
Western_ Australian administrative_ health
conditions Turkey
nursing-sensitive science treatment hf
hf am odds
miRNAs noncoding RNAs binding messenger RNA
free-breathing pulse_ sequence myocardial changes swine tachycardia-induce heart_ failure
hpEF ivabradine
pf New York_ Heart_association
eds responsable diagnosis_de_ heart_ failure ed
Cardiac c-Kit cardiac explant-derived cardiac_fonctions myocardial_ infarction
pathophysiology hf medical management pathophysiologic
inhibitor jq1 BETs chromatin RNA_polymerase
NPs heart_ failure pulmonary_embolism diabetes chemotherapy
heart_ failureHF acute_ myocardial_ infarctionAMI pneumonia pna
intestinal_ dysfunction disturbed_ intestinal_ barrier chronic_ inflammatory_ state catabolic_anabolic_ imbalance cardiac_caxia CHF
heart_ failure ejection_fraction hpEF
adenosine_ monophosphate cAMP cyclic_ guanosine_ monophosphate cgm failing_ hearts
mortality healthcare management telehealth congestive_ heart_ failure chronic_ obstructive_ pulmonary disease diabetes mellitus
catheter ablation atrial_ fibrillationAF heart_ failure preserved_ejection_fraction hff
ischemic-hypertensive_ cardiomyiopathy angina inducible_ myocardial_ischemia coronary_ arteries
RA methotrexate tNF antagonist non-biological disease antirheumatic drug nbDMARD
cox proportional_ hazards ie acute_ coronary_ syndromes coronary_interventions
sphingosine-1-phosphate receptor s1PR β1-adrenergic receptor g-protein-coupled heart
septal PCWPlateral
therapy atrial_ fibrillation carvedilol metoprolol
grs LVEF CV
Bradycardia metoprolol cardiac_ sympathetic_ tone CHF-inv rabbits sham-inv CHF-DNx
cp-recommended pharmacological treatment device ventricular
Nordic_ walking cardiac_ rehabilitation functional_capacité heart_ failure
rad_q66p inhibitory actions rad cava cav channel_isoforms heart
EFLCx LAD stenting left ventricle LCx LAD
signalling_ cascades microRNAs bHLh transcription_ factor_ Hand2 postnatal_ mammalian_ myocardium embryonic_ gene programs heart_ failure
ERC DAPc protein sarcomeric_microstructure Skm myofibre regeneration
mva implantation leaflet_ motion leaflet_réection edge-to-edge anastomosis
hART New_York_ Heart_associationNYha hf self-management_ counseling HF
BET_family_bromodomain_ proteinsBETs acetyl-lysine_ reader HF
cardiac_fonction echocardiography diastolic_ dysfunction ejection_fraction
aldosterone_ antagonism heart_ failure aldosterone neurohormone electrolytes heart_ failure
EH LV complianceLV end-diastolic_ volume LV end-diastolic_tension hg coefficient
grade
hf
right heart_ circulatory_ failure
voltage-gated ventricular action excitation-contraction e coupling myocardium
AT1 receptors neprilysin blocks renin-angiotensin-aldosteronRAS vasodilatory diuretic
ivabradine ventricular filling heart_ failure preserved ejection_fraction hpEF
blood transfusions iron erythropoiesis-stimulating agents anemia congestive_heart_ failure coronary_ heart_de_transfusion
bp glomerular filtration_ rate hypertension transmitral e-wave diastolic_metral_ annular
β-blockade disease_ progression cAMP-dependent_ protein_ kinase pKA β-adrenergic receptor
erythropoiesis-stimulating agent_therapy benefits venous thromboembolism
clinical genetic CHF
black_race mortality hospitalizationhazard cardiovascular mortalityHF
chronic_ myocardial_ischemia stent polytetrafluoroethylene
Centers_for_ Medicare_ and_ Medicaid_services cms mortality readmission penalties
heart_ failureHF tumor_ necrosis factorTNf tNF
signal_transduction_ cascade transcription factors pathological changes cardiomyocytes transcription factors epigenetic changes chromatin
temps-dependent physician discharge death
oxygen_uptake metabolic exercise cardiac kidney hz
annular_ size_reduction surgery diastolic_ mitral valve_ tethering anterior leaflet_ opening papillary_ muscles ventricular_ dilatation
hff sodium-restricted DASh ventricular_ diastolic_fonctionnement arterial_ elastance ventricular-arterial coupling
CHF ht polymorphisms anthracycline metabolism iron_ homeostasis anti-oxidant_de_fence myocardial remodelling
figure CAD diameter_ stenosis CAD descending_ artery
heart_ failure acute_méocardial_ infarction acute_méocardial_ infarction Western_ Australia
Randomized aldactone_ Evaluation_ Study chronic_ advanced_ heart_ failure aldosterone_ antagonist spironolactone mortalité
medication nonadherence salt
pathophysiological
lVAD albumin hypoalbuminemia
scientific literature hm_ II HeartWare économique h
creatininehazard dL post-transplant mortality
implantation lVAD transplantation bt dt medical therapy
radial_ artery_ tonometry p ICU
HR variability_turbulence HR variability_turbulence
dopamine nesiritide renal_fonctionnement acute_ heart_ failure renal_ dysfunction
glomerular_ filtration
Medicare coverage breast cancer chemotherapy sEER-Medicare Texas Cancer_ Registry_Medicare
signalling signalosome_ complex scaffold_ protein kinases sequential_phosphorylation
magnetically levitated centrifugal-flow lVAS
cardiomyocytes pde2 activity cgMP nitric_ oxide pde2
ejection_fraction natriuretic_peptide heart_ failure guideline-Heart_ Failure
beta1-adrenergic receptor sphingosine-1-phosphate receptor s1PR cardiac_ hypertrophic heart_ failure s1PR cardiac gene therapy
ECs HDl phosphorylation eNOS-Ser eNOS-Thr PKc-βII-Ser p70s6K-Ser
rcs sts hm sts TM
mouse ventricular_ myocytes sarcomere
administrative databases Alberta discharged_ alive hospital heart_ failure
PASp walking
ct temps hf LVEF
heart_ failure histologically myocardial_ collagen tissue
l-dKO mice cardiac iRS1 iRS2 heart_ failure impaired cardiac_énergie_ metabolism protein_ kinase
nicorandil doxorubicin heart_ failure hemodynamic perturbations mitochondrial_ dysfunction ultrastructural antitumor
Rhythm_control_therapy af atrial structure sinus rhythm rhythm
RR heart_ failure bisphophonates crude RR
physician_adherence heart_ failure Clinical_ Practice_ Guideline pg heart_ failureHF
acute_ heart_ failure renal_ dysfunction low-dose dopamine nesiritide renal_fonctionnement diuretic therapy
HF body_ compositionskinfold_ thickness dual-energy X-ray_ absorptiometry echocardiography blood
high-cost Medicare fee-for-service_ beneficiaries Centers_de_ Medicare Medicaid services
hospitals heart_ failureHF conditions acute_ myocardial_ infarction pneumonia conditions
heart_ failure
kccq New York_ Heart_association HFpEF hf
aCP restrictive_ red_ blood_cell_transfusion hemoglobin hemoglobin
implanted left-to-right interatrial shunt haemodynamic heart_ failure ejection_fraction
Caloric_restriction Aerobic_ Exercise Peak_oxygen_ Consumtion Heart_ Failure ejection_fraction
ventricular_assist devices lVADs chronic_ end-stage_heart_ failurebridge_ to_ transplantation bt transplant-ineligible
ventricular-pulmonary_ arterial couplingpulmonary_ vascular_ resistance right ventricular_ ejection
carvedilol metoprolol implantable implantable_ cardioverter-de_fibrillator_therapy MADit-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization Therapy
glucocorticoids hf
HR ivabradine EaTAC
HFPSI medical hospitalization HF HF
CHm adjunctive_ treatment dCM heart_ failure
carvedilol therapy metoprololhazard
testosterone exercise_ rehabilitation CHF testosterone
VO2 change lean_ body_ Mass change thigh muscle intermuscular_ fat
guidelines-Heart_ Failure hf
cox figure PASp
cardiac insulin-resistance mitochondrial_ oxidative metabolism cardiac hypertrophy energie_ deficit hypertrophy heart_ failure
rad rad rem rem2 rad Gem_Kir monomeric_g proteins ventricular action EC coupling gain cardiac channel_ activity
annular_ size_reduction surgery diastolic_ mitral valve_ tethering anterior leaflet_ opening papillary_ muscles left ventricularLV dilatation
pathophysiology heart_ failure preserved ejection_fraction hff myocardial_ extracellular_ matrix accumulation
breathing_control cardiac_ arrest pulseless ventricular_ fibrillationPVf implanted cardioverter-defibrillator
probNPNT-probNP proanpMR-proanp adiponectin CHF bmi FM
acetylcholinesterase inhibitor_ pyridostigmine sympathovagal_ balance cardiac_ remodeling cardiac HF myocardial_ infarction
cardiac_ sympathetic activity i-meta-iodobenzylguanidine i-mBG β-blocker
Swedishweb-system evidence-based_care Heart_ disease Therapies caBG Sweden
LVEF reverse remodeling temps hz
brain_ natriuretic_peptide bNP bNP bNP
pde_ superfamily pde2 cgm cAMP_hydrolysis negative cross_ talk cgm cAMP
tAPselongitudinal RV_ fiber_ shortening PASpforce RV in vivo RV length-force
mitochondrial-targeted antioxidant Szeto-SchillerSS cardiac_fonctionnement proteomic remodeling
économique_ Analysis Patient_management_ Interventions Heart_ Failure Cost-efectiveness_ Model coût-effectiveness disease management_ programs_ in_ heart_ failure
re-hospitalization admissions
coprimary_ end points cumulative_ urine change serum_ cystatin
financiers cardiac_ arrest cardiopulmonary_ resuscitation cPR posterior_ wall_ infarction cardiac
diabetes saxagliptin sitagliptin pioglitazone second-generation_ sulfonylureas long-acting insulin
hyperkalemia mineralocorticoid_ receptor_ antagonists race mineralocorticoid_ receptor_ antagonists heart_ failureHF
aCP erythropoiesis-stimulating agents anemia congestive_ heart_ failure coronary_ heart
heart_ failureHF ejection_fractionrEF renin-angiotensin_systemRAS β-blockers mortality
uPR sCN5a ventricular_ systolic_f tissue induced_ pluripotent_ stem_cell-derived_ cardiomyocyteshiPSc-CMs
ocp CHF cRF icc kappa
implantable cardioverter-defibrillator implant end-of-life
heart_ failure left_ventricular_ ejection_fraction aerobic trainings dynamic_ resistance
heart_ failure myocardial_fonctionnement ventricles
décision-support financial incentives cochrane_ Effective_ Practice organisation_of_care_ Taxonomy
mouse rad murine rad kv currents cav
implantable implantable_ cardioverter-de implantable implantable_ cardioverter-de_condensateur_ shocks
mouse_ heart_ failureHF hypertensive_ heart_ disease hd pathophysiology hd
MI early-onsetHF
Medicare patients acute_care hospital hm pna
ctnt NT-probNP aRIC HF figure aucs continuous_nrIs
Cardvascular_ events sst2 mdp metoprolol
incubation_de_ EC HDlNYha-IIIb phosphorylation eNOS-Ser phosphorylation eNOS-Thr HDl
hf LVEF long-term_ mortality LVEF
sarcoplasmic_ reticularSR ca(2+)-uptake protein SR ca(2+)-pump phospholamban infarcted_ hearts metoprolol
left_ventricular_ longitudinal_ systolique_ strain grs left_ventricular_ mechanics cardiovascularCV atrial_ fibrillationAF
early-onset late-onset HF hf EF HF MI
carvedilol Willebrand metoprolol β2-adrenergic receptor_haplotype
exercise intramuscular testosterone_ supplementation chronic_ heart_ failure chf low_ testosterone
heart_ failureHF plasma b-type_ natriuretic_peptide bNP ejection_fractionEF HF
grs left_ventricular_ ejection_fractionLVEF systolic_ mitral_ annulus_ velocity CV
RM telemonitoring tm implanted_ monitoring devices medical contact sts contact hm
Timed_up_go tug chronic_ obstructive_ pulmonary disease coPD chronic_ heart_ failure chf chronic_ renal_ failure crf
temps-dependent cox_regression therapy beta-blockers beta-blockers antitachycardia_pacing aTP shock therapy
ethically_ complex situations pediatriques families religious_ beliefs life-sustaining_ treatment legal_ majority
patient_ preferences prescribing guideline-recommended medications medical records performance
coût rhythm-control rate-control
ventricular ejection_fraction egf
CD34_vegf2 functional_puissance figure VO2
fit unfit cRF hazards fit unfit
Medicare Patient_ Safety_monitoring_system mpSMS adverse_ event_ rates acute_méocardial_ infarction congestive_ heart_ failure pneumonia conditions surgery
HFPSI blood_ urea_ nitrogen natriuretic_peptide New York_ Heart_association diabetes atrial_ fibrillationflutter
crte hazard
crude figure-fatalityHF HF
heart_ failure ejection_fraction
CHF race_ethnicity anthracycline
tension figure kcl-KI treatment titin extracellular_ matrix Fpassive
aerobic resistance training avantages exercise_ capacity muscle_ strength cardiacNT-probNP inflammatory i6 hsCRp
hospital_ performance all-cause_ readmission acr Potential_ Preventable_ Readmission pPR Centers_de_ Medicare Medicaid cms
heart_ failure myocardial_ infarction m β-adrenoceptor_blockade infarcted rats metoprolol
rehabilitation walking Minnesota quality_of_ life
congestive_ heart_ failure ed
accumulation arginine_ vasopressin aVP physiologique_processes CHF aVP vasopressin_ receptor_ antagonist_therapy CHF
medication physical therapy implantable_defibrillateurs circulatory_support transplantation heart_ failure
Rats hearts caspase activity phosphocreatine adenine cytochrome bcl2 Bax caspase
ventricular_pacing Bax bcl-2 Caspase-3 RTq-PCr interventricular_ septum biopsies beagle dogs heart_ failure
angiotensin-converting_ enzyme inhibiteursangiotensin_ receptor_blockers β-blockers heart_ failure ejection_fraction
sodium-restricted hypertension dietDASh ventricular_ diastolic_fonctionnement arterial_ elastance ventricular-arterial coupling hf
acute_HF RELAx-aHFASTRONAUT PRONTO patient_enrollment
metoprolol carvedilol sympathetic_ activity Willebrand_ factor
Hospitalized hf International_ Classification_of_ Diseases Clinical_ Modification codes principal_discharge
rad Q65p gating_ movement wild-type_rad Q65p impair l-type_ channel_ inhibition RGK
heart_ failure proteomics changes actin_ cytoskeleton SS20 mitochondrial metabolic
ecardiograms left ventricular base midpapillary IVc BiVP ste twist basal rotations rs
pyridostigmine coronary_ artery_ ligation cardiac_vagal cardiac_ remodeling ventricular_ dysfunction hz
New York_ Heart_associationNYha class_ II_ Heart_ Failure eplerenone Heart_ Failure MedicinesEMPhaSIS-HF
discharge follow-up
life_ expectancy heart_ failure
heart_ failure_discharges University_of_connecticut_health_ Center
Pulmonary_passillary_wedge_tension hg hg right_ atrial_tension pulmonary_ arterial_tension pulmonary_ resistance
acute_ heart_ failureHF pharmacologic studies calcium-sensitizing agents endothelin vasopressin adenosine
New-onset aortic_insufficiency i mechanical_ circulatory_support continuous_ flow ventricular_assist devices lVADs pulsatile devices
hf phenylephrine haemodynamic_ stress transverse_aortic_constrictionTAC jq cardiac_ hypertrophy
drugs raas direct_renin inhibitors endopeptidase inhibitors vasopeptidase inhibitors angiotensin receptor_blockers
pde2 overexpression cardiomyocytes cAMP ca2 inotropic
bottleneck_ stent implanted left_ anterior_ descending la proximal_ circumflex artery lx proximal_LCx LAD
acute_méocardial_ infarctionAMI heart_ failureHF complicatingAMI
i-mig cardiac_ washout carvedilol metoprolol β2-adrenergic
Muscle_ aerobic_ capacity postexercise phosphocreatine_resynthesis Fontan
Cardiac_resynchronization_therapy cRT dialysis-dependent patients heart_ failureHF cRT dialysis
eplerenone hyperkalemia renal_fonctionnement EMPHASIS-HF epleren_in_ Mild Patients Hospitalization Heart Failure
h-dKO ventricular_ mass cardiac_ apoptosis fibrosis Aktforkhead cardiac metabolic_ gene expression ATP
ATP shock_therapy
cardiorespiratory_ fitness crf body_ mass index heart_ failureHF cardiovascular risk factors HF mortality
postmarketing trials hospitalized_ heart_ failure hHF dipeptidyl_ peptidase-4 dp-4 antihyperglycemic agents
quality_ improvement database multivariable_cox modeling Heart_ Failure_ Patient_ Severity_ Index hPSI University_de_ Michigan HF
Heart_ rate hz cardiac patients acute_méocardial_ infarctionAMI congestive_ heart_ failure chf left_ventricularLV
neonatal rat ventricular_ cardiomyocytes chronic insulin iRS1 iRS2 insulin_action cardiac_ dysfunction insulin_ resistance diabetes
ventricular_ midpapillary atrioventricular_delay avd interventricular_delay vd ste circumferential_ strain radial_ strainRS
New York_ Heart_associationNYha functional class_ III HF ejection_fractions chronic guideline-directed_ medical therapy dm
LBBB QRs
pka change regulatory rob catalytic cα phosphorylation hz
dyssynchronous HF myofiber septum myofiber stretch
CHF-derived c-Kit transforming_ growth_factor-β tGF-β epithelial transition pluripotency shams
label-free shotgun proteomics changes transverse_aortic_constrictionTAC heart_ failure
hf ventricular_ ejection_fraction hfpEF left_ventricular_ ejection_fraction RAS- β-blocker HF
activation p70s6 k PKc-βII HDl jha-IIIb malondialdehyde
g-protein-coupled receptors
weight
NT-probNP inflammatory_ biomarkers hs crp il hs crp
ejection_fraction frail biological_ phenotype
resting_HR VO2max
tf-β inhibition c-Kit_cell cardiac_progenitor_fonctionnement
BETs neurohormonally_ induced heart_ disease jq phenylephrine-mediated hypertrophy cardiomyocytes pathological gene_ induction
concentric_ remodeling cr concentric_ hypertrophy hz left_ventricularLV remodeling heart_ failure ejection_fraction hpEF eccentric_ hypertrophyEH
BAT pro-brain natriuretic_peptide heart_ failure GDm-treated NYHA
mlf
nonpace dx ham-inervated ham-inv nonpace h-dx pace_non-dx chf-inv pace_ DNx chf-dx
Exercise temps PSs btes exercise temps PSs btes
hemoglobin hgb HRQoL training-induced changes HRQoL patients Heart_ Failure Exercise_ TrainingHF-action
RV RV_ dysfonctionnement confidence_ interval cachexia
atrial_fbrillation congestive_ Heart_ Failure expenditures Québec rhythm rate-control treatment coût-minimization
calcineurin nfat md-25 expression helix-loop-helix bHLh transcription_ factor Hand diseased human mouse_ myocardium
heart_ failure myocardial_ischaemia bradyarrhythmias valvular_regurgitation pulmonary_ embolism infection renal dysfunction
hABC Battery HF Health ABC HF hf SD death
NT-probNP
prognostic_puissance r-r interval_ oscillations HR fractal_ scaling
heart_ failureHF ventricular_tachycardiaHFVT VT structurally_ normal hearts hnorm
grs cox model chronic_ heart_ failure hypertension diabetes stroke glomerular_ filtration_ rate LVEF CV
diastolic filling relaxationviscoelastic passive_stiffness doppler_ mitral inflow_ velocity e-wave
VAD ventricular_assist_ device_support edmo extracorporeal_ membrane_ oxygenation_ membrane VAD
mt NYha HFpEF hf therapy HFpEF deathHF
cost-effectiveness heart_ failure_ disease_management
resistin heart_ failure mouse murine_ resistin transgenic Retn_ gene hum-retn_mice inflammation-stimulated
angiotensin-converting_ enzyme_ inhibiteursangiotensin receptors β-blockers
ttetMena_mice cardiac_ injury ejection_fraction fractions heart_ dilatation hypertrophy transverse_aortic_constrictionTAC
heart_ failure Italy cfa SCHFISelf-Care_ Maintenance Self-Care_management Self-Care_ Confidence
resynchronization-Defibrillation Ambulatory_ Heart_ Failure implantable cardioverter_de_fibrillator-cRT mortality heart_ failure
ischemic events ies ischemic_ cardiomyopathy icc cardiac_resynchronization therapy defibrillator ct-d
renal_ dysfunction chronic_ obstructive_ pulmonary disease diabetes peripheral_ vascular disease left ventricular_ ejection_fraction iCD shocks mortality ischemic_ cardiomyopathy
CHF SD testosterone
Raf-MEK1/2-erk scaffold_ proteins cardiac_ remodelling
functional MS LV dilatation heart_ failure hz LV functional_ ms hz MR prolapse degenerative_ mitral valve
angiotensin converting_ enzyme_ inhibitor angiotensin-receptor β-blockers heart_ failure medications
New York_ Heart_association kccq HF EF HFpEF
LV ejection_fraction strain_de_strain_ rate diastole strain_ rate diastole transmitral_ flow sinus rhythm
c57b infusion uninephrectomy ANG infusion salt_ loading ANG infusion uninephrectomy salt
transmissionral_ blood_ flow_ velocity doppler_ early_ diastolic_metral_ annulus pulmonary_caillary_wedge_tension pdp systolique_ heart_ failureHF
VO2 exercise masse
AMI hospital odds dying
kccq HFpEF
sex-specific ctnt NT-probNP ctnt NT-probNP HF
Mass_spectrometry circulating NT-probNP physiological_ proteolysis
HFpEF New York_ Heart_association mean_ ejection_fraction Fes
depressed_ left_ventricularLV pressure pressure ejection_fraction fraction_ shortening cardiac_ output LV end-diastolic_tension MI metoprolol
baroreflex_ Activation Therapy Heart_ Failure Reduced_ejection_fraction carotid_ baroreflex_activation_therapyBAT heart_ failureHF
enrollment
hf hf raised_ blood_ glucose levels obesity tobacco aging hypertensionSH rheumatic_ fever Chagas disease cd
age-et_sex-adjusted risk hz
cf normal overweight obese body_ mass
egf egf egFR hypertension diuretics temps ESRD
myocardial_phosphodiesterase-2 pde heart_ failureHF pde beta-adrenergic receptorβ-AR cardiomyocytes
heart_ failure cardiac_resynchronization_therapy defibrillator implantable cardioverter-defibrillator device carvedilol ATP shock_therapy metoprolol
ERC epicatechin-rich cocoa Skm mitochondrial_ structure rob ramirez-sanchez ciaraldi perkins Murphy naviaux Hogan ceballos maisel Henry
consultations urgent_ readmission physicians
Mena_overexpression TTA TAC surgery cardiac_ hypertrophy TTA TAC cardiac_fonctionnel
p diuretic_refractory hf prelated complications
ATP aac mitochondrial oxidation glucose lactate fatty acids myocardial_ glycolysis
proangiogenic effects b VEGF_ pathway adenoviral_ vector decoy VEGF receptor ad-flk adenovirus ad-c
eplerenone potassium potassium hyperkalemia medication
implantation bottleneck stent proximal LADLCx reversible_ myocardial_ischemiaopen stent ischemic_ heart_ failure stent
New York_ Heart_association class_ III_ heart_ failureHF ventricular_ejection_fraction permanent_ breathing p
potassium spironolactone AAs race_de_réquence
cPET CHF exercise exercise rehabilitation
echocardiography LV end-diastolic ml mitral valve mva pressure hg
surgery post-liVAD aortic_ valve leaflet repair bioprosthetic aortic_ valve_ replacement CF lVAD
VA health_cares systolic_ heart_ failure β-blocker angiotensin converting enzyme_ inhibitor angiotensin-receptor_blocker
exercise-induced pulmonary_ artery_ systolic_tensionPASp stress doppler echocardiography right ventricular_contractile_ reserve pulmonary_ hypertension right_ heart_ failure
MEDLINEEMBAse HEalthSTAR cINAHL cochrane_ Library Joanna_ Briggs Institute_evidence_ Based_ Practice
heart_ failure neuro-hormonal_système angiotensin converting_ enzyme_ inhibiteursangiotensin converting_ enzyme_ inhibiteurs_ intolerance
open_ chest_model twist RS RS_synchrony ste rte rvpo changes RS_synchrony CS BiVP
TAPse PASp tAPse-to-passp ratio figure cox_regression Kaplan-meier
obeseSD body_ mass_ index hfEF
heart_ failure hz mRNA voltage-gated_ cardiac na_subunit sn2 truncated_nonfunctional channels endoplasmic_ reticulum
paedic_ heart_ failure myocarditis dilated_ cardiomyopathy heart_ failure anthracycline malignant_ disease
économique_ Analysis Patient_management Interventions Heart_ Failure Cost-effiectiveness_ Model
natriuretic_peptidesNPs b-type_n-terminal_pro-b-type_NP acute_ heart_ failure Emergency_ Department ed acute_ dyspnea
oxygen_ consumption VO2ven vco2 ventilation eOV pressure end-tidal CO2PETco
Denmark bisphosphonates raloxifene
longitudinal_ strain left_ventricle echocardiographic
hypertension LV dilatation LV dysfunction MR MS mitral valve closure organic lesion systolic diastolic_ tethering functional_ etiology MR MS
HDl healthy controls hdl CHF-NYha-III hdp CHF-NYha-II hd
platelet-activation factor pf metabolic_ enzymes heart_ failure bmi
acute_care_ surgery acs oHT transplantation medical therapy m intravenous_ inotropes ventricular_assist devicesVADs
renin-angiotens-aldosterone_systemraas hf angiotensin-converting_ enzyme_ inhibiteurs angiotensin_ receptor_blockers aldosterone_blockade hpEF
hpf ivabradine ventricular filling_tension
admission lVET
heart_ rate blood_tension renal_fonctionnement spironolactone RAS
cardiac_ performance β-adrenoceptor_blockade heart_ failure SR ca(2+)-pump cardiac_ remodeling plasma_ catecholamines
SS31 congestive_ heart_ failure mitochondrial_ damageTAC mitochondrial_proteome changes mitochondrial nonmitochondrial_ protein
HF-action HF ventricular_ ejection_fractions HRQoL Kansas_ City Cardiomyopathy_ Questionnaire kccq
tolvaptan hyponatremia japon congestive_ heart_ failure diuretic therapy serum_sodium
myofibrillar ATPase mRNA ca(2+)-pump phospholamban α-myosin_ heavy_ chain mRNA β-myosin_ heavy_ chain metoprolol
anesthetized dogs coronary_ microembolization-induced hz cXL ventricular_ end-diastolic pressure myocardial_ oxygen ejection ventricular_power
heart_ failure t1-mapping agents
mdc mdc mdc
hf idiopathic dilated cardiomyopathy cd ischemic SH valvular alcohol
ST2 functional_capacité ambulatory patients HF Heart_ Failure Exercise_ Training h-action exercise_training HF
implantable_carvedilol metoprolol implantable cardioverter-de_fibrillator therapy MADt-cRT multicenter_automatic_ Defibrillator implantation Cardiac_resynchronization Therapy
angiotensin-converting enzyme inhibiteursangiotensin receptor_blockers β-blockers
ischemic_HF NYha_fonctionnel glomerular_ filtration_ rate heart_ rate hypertension diabetes mellitus myocardial_ infarction
ct systolique_ dysfunction resynchronization_reverses_remodeling Systolique_ left_ventricularLV ejection_fractionLVEF
β1ARs s1PR1s myocyte action cAMP receptors g-protein-coupled receptor_ kinase
pf-cp pf lyso-paf-at pp-PLA2
aUC
Rate-control cardiac procedures cardioversions costs antiarrhythmic drugs
spironolactone hospitalization
diabetes_ mellitus cardiomyopathy β-blocker angiotensin-converting enzyme_ inhibitor angiotensin_II receptor_blocker
epleren_ Post_myocardial_ infarction Heart_ failure edheSUS post-myocardial_ infarction heart_ failure aldosterone_ antagonist_ epleren
cardiopulmonary_ exercise rehabilitation patients_ with_ chronic_ heart_ failure chf CardioPulmonary_ Exercise_ Testing cPET exercise_ rehabilitation
risk_reduction heart_ failure-related mortality sudden_ death
DASh sd brachial_synchron_tension hg central_en-systolique_tension hg
all-cause_ mortality hf LVEF Heart_ Failure Survey ISrael
hf obese body_ mass_ index black_ ethnicity idiopathic-dilated_ cardiomyopathy
ventricular ejection_fraction World_ Health_ Organization idiopathic_ dilated_ cardiomyopathy negative coronary_ angiography
European Society_of_ Cardiology hff heart_ failure LV ejection_fraction_de_a_non-dilated_ left_ventricle diastolic_ dysfunction relaxation LV diastolic_ stiffness LV filling_tensions
glomerular_ filtration edf diabetes cholesterol lDL-cholesterol CLCNka_GG
ecardiography LV end-diastolic_dimension LV end-diastolique_tensionwall_ stress lung_ weight acf sham
heart_ failuremean_ ejection_fraction cardiac_ rehabilitation_care Nordic_ walking
ds-stratified hazards sitagliptin pioglitazone sitagliptin sulfonylureas sitagliptin insulin
skeletal_ muscle_ mass t-score sarcopenic_ range_système_de_distribution
RAS- β-blocker mortality hf hf
testosterone oxygen_uptake Beck_depression_inventory leg_ strength Medical
Heart_ Failure figure Exercise_ Training h-action social_ support score ps barriers_ to_ exercise btes
ST2 cardiovascular death hz mortality
New York_ Heart_association cardiopulmonary_ exercise lean_ mass x-ray_ absorptiometry dXA calf_ muscle magnetic_ resonance_ spectroscopy
dopamine nesiritide diuretic therapy renal_fonctionnement acute_ heart_ failure renal_ dysfunction
crte New York_ Heart_association heart_ failure left_ventricular_ ejection QRs echocardiographic ventricular_ dyssynchrony
ventricularLV ejection fraction hf right-side_ cardiac catheterization transthoracic echocardiography transmitral_ flow mitral_ annulus diastole
acute_ coronary_ syndromes CAD bNP NT-probNP CAD
hf lyso-paf-AT PAf-cp PAf pp-PLA2
medical therapy sternotomy aortic_ valve bioprosthetic valve_ replacement dacron patch_closure aortic_ valve transcatheter aortic_ valve surgery aortic_ valve
cutoff_value plasma N-terminal pro-b-type_ natriuretic_peptideNT-probNP acute_ heart_ failureHF emergency_ department ed
cardiac_ troponin t ctnt natriuretic_peptideNT-probNP HF HF Atherosclerosis_ Risk_in_communautésARI
body_ Mass_ index h fat_free_ mass
figure body_ mass_ index advanced COPd CHF cRF
reverse_ remodeling ejection_fraction mortality hz dialysis
EH LV_contractility LVEF coefficient ratio_de_système_ blood_tension end-systolique hg
ecardiography dilated LV end-diastolic ml ejection MR mitral valve_ opening ms mva pressure hg
double-blind placebo-controlled clinical_ trialROSe acute_ heart_ failure renal dysfunction glomerular filtration
BETs chromatin-mediated signal_transduction Pol_II co-activation transcription_ factor_nets hz nucléaire_ factor_of_activation_ T cells naFAT nuclear_factor-κbNF-κb transcription_ factor
mortality cardiovascular events myocardial_ infarction congestive_ heart_ failure arrhythmia cardiac_ death hypertension venous thrombolic events ischemic_ cerebrovascular
e-cfus diabetes e-cfu VO2 diabetes e-cFUs
all-cause cardiovascular mortality multivariable
immunoblotting radioenzymatic- and fluorescence_ resonance_énergie_ transfer-based_assays video edge_ detection epifluorescence_microscopy ca2 myocardial_ tissus cardiomyocytes hz
Exercise_puissance oxygen_ consumptionVO2 qol Minnesota_ Living_ with_ Heart_ Failure mlf heart_ failure
eAST atrial_ fibrillation Stroke_prevention af strokeCHA2ds2VASc rhythm_control therapy
ventricular_ ejection_fraction hf ventricular_ejection_fraction hospital acute_en_ outpatient
TAC-induced_ proteomic alterations mitochondrial-targeted_peptide SS31 mitochondrial_fonctionnement TAC mitochondrial-targeted_peptide_ drugs heart_ failure
hf left_ventricularLV ejection_fraction hpEF echo-Doppler pro-brain-type_ natriure
low-volume eds hospitalized odds ratio high-volume eds
habb Battery_ scores Health ABC HF Risk_Model discrimination c-indexnet-reclassification-improvement hz
cardiac transplant ECCT diabetes mellitus chronic_ kidney_ disease glomerular_ filtration
struct_ validity cf msea Self-Care_ Maintenance_ Scale cf msea Self-Care_management_ Scale cf msea Self-Care_ Confidence
BAT distance_ walked quality-of-life score NYha
preoperative hypoalbuminemia postoperative_ normalization_de_albumin_ levels hypoalbuminemia lVAD
rehospitalization acute_méocardial_ infarctionAMI kidney infection urinary_ tract_ infectionUTI
heart_ failureHF ischemic cardiomyopathies pharmacological armamentarium implantable_ cardioverter_defibrillateurs cardiac_resynchronization_therapy cardiac transplantation ventricular_assist devices
SAF pf catheterization central_venous_tension hg hg sVR dyn cardiac
admission median_bp EF bNP
heart_ failure_admission heart_ transplantationLV_assist_ device death
LV ejection_fraction vitesse_de_ circumferential_ shortening elastance contractile_ efficiency acf allopurinol rats o2 cardiomyocytes extracellular_ flux
hpEF LV_structure normal_geometry LV hypertrophyLVh wall_ thickness cr LVh WT
angiotensin receptor_ neprilysin_ inhibitor neprilysin_ inhibitor_prodrug angion_ receptor_ antagonist_ valsartan hypertension heart_ failure ejection_fraction
blood_tension hg mitral valve plasty degenerative MR prolapse chordal ruptures triangular resection edge-to-edge anastomosis ring_ annuloplasty Physio Ring edwards_ Lifesciences irvine
shuttle_ walk oxygen_uptake muscular_ strength echocardiographic measures pro-brain natriuretic_peptide depression beck_depression_inventory minnesota Heart_ Failure Medical
LVEF long-terme mortality LVEF
horn-kyto lean zs1 obese Zs1 high-fat diet metabolic renal echocardiographic evaluations hemodynamically euthanization
Kaplan-meier log-rank
af af hypertension sinus rhythm
HF-ref NYha_fonctionnel egf potassium eplerenone hyperkalemia Wf
ffff body_fréquence dual_énergie X-ray_ absorptiometry dXA non-diabetic patients chronic_ heart_ failure chfcc non-cachectic CHF myocardial_ infarction-both
drug dose spironolactone end point_de_ death hh AAs
pulmonary_ arterial_hytension inoperable chronic thromboembolic pulmonary_ hypertension impaired ventricular_pump pulmonary_ arterial_ hypertension medication stress echocardiography cardiopulmonary_ exercise
cardiovascular_ death HF btes btes cardiovascular_ death HF
index_ed_ visit low-volume ED death readmission aOR high-volume eds
implantable implantation implantation implantable implantable_ cardioverter-de_de_activation
Cardiac_ magnetic_ resonance left_ atrial pulmonary_ vascular_ resistance cardiac
hf ventricular_ejection_fraction HF New York_ Heart_association echocardiographic cardiopulmonary
heart_ failure ABCd American_ College_of_ Cardiology accAmerican_ Heart_association AHA New_York_ Heart_associationNYHA structural_ heart_ failure
mva continuity_ equationLV end-diastolic volume end-systolic mva velocity_time mitral_ filling_ flow doppler echocardiography MR mitral_ valve plasty
statitistical significance RM mortality sts hm cri
HFPSI Ann_ Arbor Veterans_ Affairs hf clinic v-rt VA HFPSI
AAs spironolactone hyperkalemia potassium hypokalemia
LVEF long-terme_ mortality LVEF LVEF
hpEF HFpEF genderodds NYha distance walk_ test mwt medications
echo-derived pulmonary_ arterial_ systolique_tensionPASp right_ventricularRV tricuspid_ annular_ plane_synchron_excursionTAPSe diastole end-systole heart_ failureHF cardiac
CAD diabetes electrocardiographic_q_ waves bundle_ branch_ block nondiabetes dyslipidemia hypertension tobacco
receiver_ operating_ characteristic_curve uc pWP
trastuzumab-treated patients coronary_ artery disease hypertension trastuzumab administration CHF
LVEF crte crte_on crte_ OFF LV end_ systolic_ volume_ index mdp LV
TGF-β signaling TGF-β receptor smad small-molecule_ inhibiteurs c-Kit epithelial mesenchymal transition markers pluripotency marker nanog c-Kit_cell cardiomyocyte
hf diuretics co-morbidités mwt NYha
surgery hf postoperative echocardiography LV end-diastolic LV ejection_fraction MR mitral valve_ opening mitral_ valve mva pressure hg
implanter_heart_ failure ivabradine SHIFT Systolic_ Heart_ Failure inhibitor_ Ivabradine_trial ivabradine echocardiographic
pse psap hg pse New York_ Heart_association_fonctionnel
Renal_fonctionnel Chronic_ Kidney Disease Epidemiology glomerular_ filtration_ rate egf mL
paraDIGm-HF chronic_ heart_ failure systolique_ dysfunctionLV functional class NYha bNP bNPcardiovascular_ death hospitalization heart_ failure ARni lz696 sacubiltril valsartan
hyperkalemia African_Americans as as New York_ Heart_associationNYha class_ III HF left_ventricular_ dysfunction spironolactone aldactone_ EvaluationRALes
LV reverse_ remodeling pre-cRT LV ventricular ventricular
natriuretic_peptide natriuretic_peptide coronary_ artery disease bn p p ventricular_ cardiomyocytes ventricular_ wall_ stress myocardial_ischemia
iRS2 heart hyperinsulinemia myocardial_ insulin_ resistance cellular_ dysfunction iRS2 heart-specific iRS2 double-knockout h-dKO liver-specific iRS2 double-knockout l-dKO
angiotensin-converting enzyme inhibiteursangiotensin receptor_blockers β-blockers
ivabradine change diastolic_metral_métral_annuular_ velocity exercise_puissance therapy ivabradine oxygen
liberal transfusion mortality
readmission familiar physician hazard ratio
hek embryonic_ kidney sphingosine-1-phosphate s1PR1 downregulation isoproterenol β-adrenergic_ receptor_ agonist
Kansas City Cardiomyopathy Minnesota Heart_ Failure depressive symptoms beck_depression depression natriuretic_peptide endothelial dilatation ventricular_ diastolique
cardiovascular events atrial_ fibrillation left_ventricular_ ejection_fraction diabetes mellitus peripheral_ vascular disease myocardial_ infarction heart_ failure stroke glomerular_ filtration acute_ kidney injury
inconjunction diastolic_fonctionnement ventricular-arterial coupling
disease_risk score dRS saxagliptin sitagliptin saxagliptin pioglitazone saxagliptin sulfonylureas saxagliptin insulin
revascularization coronary_ artery_ bypass surgery percutaneous_ coronary intervention systolic_ blood_tension left bundle_ branch_ block electrocardiogram
biomedical treatment chm ventricular ejection_fraction left ventricular_ diastolic_ end
heart_ failure ventricular_ ejection fraction Arg16 grn27 gly16_glu27_haplotype β2-receptor carvedilol metoprolol
low-volume ed deathhospitalization ed
health_budy mortalityhazard ratio hz inpatient admissions
multivariable-adjusted_ hazard
ctt NT-probNP aRIC hf systolic_ blood_tension antihypertensive medication smoking diabetes body_système coronary_ heart HF receiver_ operating_ characteristic_curve auc discrimination improvement nRI
eplerenone hyperkalemia renal_fonctionnement hf emPHAs-HF heart_ failure ejection_fraction h-ref New York_ Heart_associationNYha glomerular_ filtration egf serum_ potassium
low-dose_ nesiritide cumulative_ urine_ volumenesiritide cystatin
Nordic_ walking functional_ capacity mwt physical activity right_ grip_ strength depressive_ symptoms hospital anxiety_depression
hyperkalemia Wf diabetes egFR systolic_ blood_tension hg potassium hyperkalemia study-drug_discontinuation hospitalization Wfhospitalization HF cardiovascular mortality
PAf biosynthetic_ enzymeslyso-paf acetyltransferaselyso-paf-at dithiothreitol dt CDp alkyl-2-acetyl-sn-glycerol choline_phosphotransferase pf-cp catabolic_ isoenzymes pf-acetylhydrolase pf-a2 leukocytes
ivabradine follow-up_ exercise_puissanceMETs oxygen_uptake exercise-induce diastolic_metral_fréquence
CHFOdds hct chest radiation hypertension genes NAD ph-oxidase RAC2 hf doxorubicin_efflux_ transporter
NYha classification class_ II class_ III change quality_de_ life Duke_ Activity_status_ Index Kansas_city_ Cardiomyopathy_ Questionnaire
low-dose dopamine cumulative_ urine_ volumedopamine ml change cystatin_c leveldopamine
figure glomerular filtration_ rate chronic_ obstructive_ pulmonary disease diabetes ventricular_ejection_fraction iCD shocks New York_ Heart_association atrial_ fibrillation congestive_HF
oxygen_uptake ventilatory_ efficiency slope hemoglobin left ventricular_ ejection_fraction renal_fonctionnement diet renal_ disease sodium
Kansas_city_cardiomyopathy questionnaire Minnesota_ Living Heart_ Failure questionnaire Beck_depression inventory Zung flow-mediated_ dilatation_ diameter Fes natriuretic_peptide
